Expression	O
of	O
E2A-HLF	B-protein
chimeric	I-protein
protein	I-protein
induced	O
T-cell	O
apoptosis	O
,	O
B-cell	O
maturation	O
arrest	O
,	O
and	O
development	O
of	O
acute	O
lymphoblastic	O
leukemia	O
.	O

The	O
E2A-HLF	B-DNA
fusion	I-DNA
gene	I-DNA
,	O
generated	O
by	O
t	B-DNA
(	I-DNA
17	I-DNA
;	I-DNA
19	I-DNA
)	I-DNA
(	I-DNA
q22	I-DNA
;	I-DNA
p13	I-DNA
)	I-DNA
in	O
acute	O
lymphoblastic	O
leukemia	O
(	O
ALL	O
)	O
,	O
encodes	O
a	O
chimeric	B-protein
transcription	I-protein
factor	I-protein
in	O
which	O
the	O
trans-activating	B-protein
domains	I-protein
of	O
E2A	B-protein
are	O
fused	O
to	O
the	O
DNA-	B-protein
binding	I-protein
and	I-protein
dimerization	I-protein
domains	I-protein
of	O
hepatic	B-protein
leukemic	I-protein
factor	I-protein
(	O
HLF	B-protein
)	O
.	O

To	O
investigate	O
its	O
biological	O
role	O
,	O
we	O
generated	O
transgenic	O
mice	O
expressing	O
E2A-HLF	B-protein
using	O
Ig	B-DNA
enhancer	I-DNA
and	I-DNA
promoter	I-DNA
,	O
which	O
direct	O
transgene	O
expression	O
in	O
cells	O
committed	O
to	O
the	O
lymphoid	O
lineage	O
.	O

The	O
transgenic	O
mice	O
exhibited	O
abnormal	O
development	O
in	O
the	O
thymus	O
and	O
spleen	O
and	O
were	O
susceptible	O
to	O
infection	O
.	O

The	O
thymus	O
contained	O
small	O
numbers	O
of	O
thymocytes	B-cell_type
,	O
and	O
TUNEL	O
staining	O
showed	O
that	O
higher	O
population	O
of	O
thymocytes	B-cell_type
were	O
undergoing	O
apoptosis	O
.	O

The	O
spleen	O
exhibited	O
a	O
marked	O
reduction	O
in	O
splenic	B-cell_type
lymphocytes	I-cell_type
and	O
the	O
flow	O
cytometric	O
analyses	O
and	O
the	O
in	O
vitro	O
colony	O
formation	O
assays	O
showed	O
that	O
the	O
B-cell	O
maturation	O
was	O
blocked	O
at	O
a	O
very	O
early	O
developmental	O
stage	O
.	O

These	O
findings	O
indicated	O
that	O
the	O
expression	O
of	O
E2A-HLF	B-protein
induced	O
T-cell	O
apoptosis	O
and	O
B-cell	O
maturation	O
arrest	O
in	O
vivo	O
and	O
that	O
the	O
susceptibility	O
of	O
the	O
transgenic	O
mice	O
to	O
infection	O
was	O
due	O
to	O
immunodeficiency	O
.	O

Moreover	O
,	O
several	O
transgenic	O
mice	O
developed	O
acute	O
leukemia	O
,	O
classified	O
as	O
T-ALL	O
based	O
on	O
the	O
surface	O
marker	O
analysis	O
and	O
DNA	O
rearrangements	O
,	O
suggesting	O
that	O
an	O
additional	O
event	O
is	O
required	O
for	O
malignant	O
transformation	O
of	O
lymphoid	B-cell_type
cells	I-cell_type
expressing	O
E2A-HLF	B-protein
.	O

Our	O
findings	O
provide	O
insight	O
into	O
the	O
biological	O
function	O
of	O
E2A-HLF	B-protein
in	O
lymphoid	O
development	O
and	O
also	O
its	O
role	O
in	O
leukemogenesis	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

RAPID	NULL
COMMUNICATION	NULL
Expression	NULL
of	NULL
E2A-HLF	NULL
Chimeric	NULL
Protein	NULL
Induced	NULL
T-Cell	NULL
Apoptosis	NULL
,	NULL
B-Cell	NULL
Maturation	NULL
Arrest	NULL
,	NULL
and	NULL
Development	NULL
of	NULL
Acute	NULL
Lymphoblastic	NULL
Leukemia	NULL
By	NULL
Hiroaki	NULL
Honda	NULL
,	NULL
Toshiya	NULL
Inaba	NULL
,	NULL
Takahiro	NULL
Suzuki	NULL
,	NULL
Hideaki	NULL
Oda	NULL
,	NULL
Yasuhiro	NULL
Ebihara	NULL
,	NULL
Kohichiro	NULL
Tsuiji	NULL
,	NULL
Tatsutoshi	NULL
Nakahata	NULL
,	NULL
Takatoshi	NULL
Ishikawa	NULL
,	NULL
Yoshio	NULL
Yazaki	NULL
,	NULL
and	NULL
Hisamaru	NULL
Hirai	NULL
The	NULL
E2A-HLF	NULL
fusion	NULL
gene	NULL
,	NULL
generated	NULL
by	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
(	NULL
q22	NULL
;	NULL
p13	NULL
)	NULL
in	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
(	NULL
ALL	NULL
)	NULL
,	NULL
encodes	NULL
a	NULL
chimeric	NULL
transcription	NULL
factor	NULL
in	NULL
which	NULL
the	NULL
trans-activating	NULL
domains	NULL
of	NULL
E2A	NULL
are	NULL
fused	NULL
to	NULL
the	NULL
DNA-binding	NULL
and	NULL
dimerization	NULL
domains	NULL
of	NULL
hepatic	NULL
leukemic	NULL
factor	NULL
(	NULL
HLF	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
its	NULL
biological	NULL
role	NULL
,	NULL
we	NULL
generated	NULL
transgenic	NULL
mice	NULL
expressing	NULL
E2A-HLF	NULL
using	NULL
Ig	NULL
enhancer	NULL
and	NULL
promoter	NULL
,	NULL
which	NULL
direct	NULL
transgene	NULL
expression	NULL
in	NULL
cells	NULL
committed	NULL
to	NULL
the	NULL
lymphoid	NULL
lineage	NULL
.	NULL

The	NULL
transgenic	NULL
mice	NULL
exhibited	NULL
abnormal	NULL
development	NULL
in	NULL
the	NULL
thymus	NULL
and	NULL
spleen	NULL
and	NULL
were	NULL
susceptible	NULL
to	NULL
infection	NULL
.	NULL

The	NULL
thymus	NULL
contained	NULL
small	NULL
numbers	NULL
of	NULL
thymocytes	NULL
,	NULL
and	NULL
TUNEL	NULL
staining	NULL
showed	NULL
that	NULL
higher	NULL
population	NULL
of	NULL
thymocytes	NULL
were	NULL
undergoing	NULL
apoptosis	NULL
.	NULL

The	NULL
spleen	NULL
exhibited	NULL
a	NULL
marked	NULL
reduction	NULL
in	NULL
splenic	NULL
lymphocytes	NULL
and	NULL
the	NULL
flow	NULL
cytometric	NULL
analyses	NULL
HROMOSOMAL	NULL
TRANSLOCATIONS	NULL
are	NULL
recurrent	NULL
features	NULL
of	NULL
human	NULL
hematopoietic	NULL
malignancies	NULL
.	NULL

!	NULL

Consistently	NULL
observed	NULL
chromosomal	NULL
abnormalities	NULL
in	NULL
specific	NULL
tumors	NULL
indicate	NULL
that	NULL
the	NULL
underlying	NULL
genetic	NULL
events	NULL
are	NULL
essentially	NULL
implicated	NULL
in	NULL
the	NULL
causation	NULL
of	NULL
the	NULL
diseases	NULL
.	NULL

In	NULL
acute	NULL
leukemias	NULL
,	NULL
several	NULL
characteristic	NULL
chromosomal	NULL
translocations	NULL
have	NULL
been	NULL
noted	NULL
,	NULL
and	NULL
studies	NULL
on	NULL
the	NULL
chromosomal	NULL
breakpoints	NULL
have	NULL
identified	NULL
candidates	NULL
of	NULL
genes	NULL
whose	NULL
dysregulated	NULL
or	NULL
aberrant	NULL
expression	NULL
would	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
tumor	NULL
development	NULL
.	NULL

!	NULL

Transcription	NULL
factors	NULL
are	NULL
frequent	NULL
target	NULL
of	NULL
chromosomal	NULL
translocations	NULL
observed	NULL
in	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
(	NULL
ALL	NULL
)	NULL
.	NULL

Among	NULL
them	NULL
,	NULL
E2A	NULL
gene	NULL
,	NULL
encoding	NULL
a	NULL
basic	NULL
helix-loop-helix	NULL
(	NULL
bHLH	NULL
)	NULL
transcription	NULL
factor	NULL
on	NULL
chromosome	NULL
19	NULL
,	NULL
has	NULL
been	NULL
known	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
two	NULL
chromosomal	NULL
translocations	NULL
,	NULL
t	NULL
(	NULL
1	NULL
;	NULL
19	NULL
)	NULL
(	NULL
q23	NULL
;	NULL
p13	NULL
)	NULL
>	NULL
*	NULL
and	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
(	NULL
p22	NULL
;	NULL
q13	NULL
)	NULL
``	NULL
``	NULL
that	NULL
are	NULL
observed	NULL
in	NULL
human	NULL
B-lineage	NULL
leukemias	NULL
.	NULL

As	NULL
a	NULL
result	NULL
of	NULL
t	NULL
(	NULL
1	NULL
;	NULL
19	NULL
)	NULL
(	NULL
q23	NULL
;	NULL
p13	NULL
)	NULL
,	NULL
the	NULL
C-terminal	NULL
region	NULL
of	NULL
E24	NULL
gene	NULL
,	NULL
including	NULL
the	NULL
bHLH	NULL
DNA-binding	NULL
and	NULL
dimerization	NULL
domains	NULL
,	NULL
is	NULL
replaced	NULL
with	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
PBXI	NULL
homeobox	NULL
gene	NULL
on	NULL
chromosome	NULL
1.54	NULL
On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
following	NULL
the	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
(	NULL
p22	NULL
;	NULL
q13	NULL
)	NULL
,	NULL
the	NULL
same	NULL
region	NULL
of	NULL
the	NULL
EZ2A	NULL
gene	NULL
is	NULL
fused	NULL
to	NULL
the	NULL
DNA-binding	NULL
and	NULL
dimerization	NULL
domains	NULL
of	NULL
hepatic	NULL
leukemic	NULL
factor	NULL
(	NULL
HLF	NULL
)	NULL
gene	NULL
From	NULL
the	NULL
Third	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
Faculty	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Tokyo	NULL
;	NULL
the	NULL
Department	NULL
of	NULL
Molecular	NULL
Biology	NULL
,	NULL
Jichi	NULL
Medical	NULL
School	NULL
,	NULL
Tochigi-ken	NULL
;	NULL
the	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
University	NULL
of	NULL
Tokyo	NULL
;	NULL
and	NULL
the	NULL
Department	NULL
of	NULL
Clinical	NULL
Oncology	NULL
,	NULL
Institute	NULL
of	NULL
Medical	NULL
Science	NULL
,	NULL
University	NULL
of	NULL
Tokyo	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
.	NULL

Submitted	NULL
October	NULL
12	NULL
,	NULL
1998	NULL
;	NULL
accepted	NULL
February	NULL
10	NULL
,	NULL
1999	NULL
.	NULL

Supported	NULL
in	NULL
part	NULL
by	NULL
Grants-in-Aids	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
,	NULL
Science	NULL
and	NULL
Culture	NULL
of	NULL
Japan	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Hisamaru	NULL
Hirai	NULL
,	NULL
MD	NULL
,	NULL
Third	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
Faculty	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Tokyo	NULL
,	NULL
7-3-1	NULL
Hongo	NULL
,	NULL
Bunkyo-ku	NULL
,	NULL
Tokyo	NULL
113	NULL
,	NULL
Japan	NULL
;	NULL
e-mail	NULL
:	NULL
hhirai-tky	NULL
@	NULL
umin.ac.jp	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
adver-tisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

Â©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/99/9309-0145	NULL
$	NULL
3.00/0	NULL
2780	NULL
and	NULL
the	NULL
in	NULL
vitro	NULL
colony	NULL
formation	NULL
assays	NULL
showed	NULL
that	NULL
the	NULL
B-cell	NULL
maturation	NULL
was	NULL
blocked	NULL
at	NULL
a	NULL
very	NULL
early	NULL
developmental	NULL
stage	NULL
.	NULL

These	NULL
findings	NULL
indicated	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
E2A-HLF	NULL
induced	NULL
T-cell	NULL
apoptosis	NULL
and	NULL
B-cell	NULL
maturation	NULL
arrest	NULL
in	NULL
vivo	NULL
and	NULL
that	NULL
the	NULL
susceptibility	NULL
of	NULL
the	NULL
transgenic	NULL
mice	NULL
to	NULL
infection	NULL
was	NULL
due	NULL
to	NULL
immunodeficiency	NULL
.	NULL

Moreover	NULL
,	NULL
several	NULL
transgenic	NULL
mice	NULL
developed	NULL
acute	NULL
leukemia	NULL
,	NULL
classified	NULL
as	NULL
T-ALL	NULL
based	NULL
on	NULL
the	NULL
surface	NULL
marker	NULL
analysis	NULL
and	NULL
DNA	NULL
rear-rangements	NULL
,	NULL
suggesting	NULL
that	NULL
an	NULL
additional	NULL
event	NULL
is	NULL
required	NULL
for	NULL
malignant	NULL
transformation	NULL
of	NULL
lymphoid	NULL
cells	NULL
expressing	NULL
E2A-HLF	NULL
Our	NULL
findings	NULL
provide	NULL
insight	NULL
into	NULL
the	NULL
biological	NULL
function	NULL
of	NULL
E2A-HLF	NULL
in	NULL
lymphoid	NULL
development	NULL
and	NULL
also	NULL
its	NULL
role	NULL
in	NULL
leukemogenesis	NULL
.	NULL

Â©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

belonging	NULL
to	NULL
the	NULL
basic	NULL
region/leucine	NULL
zipper	NULL
(	NULL
bZIP	NULL
)	NULL
family	NULL
on	NULL
chromosome	NULL
17.5	NULL
%	NULL
These	NULL
events	NULL
create	NULL
novel	NULL
fusion	NULL
gene	NULL
products	NULL
,	NULL
Â£2A-PBXI	NULL
and	NULL
E2A-HLF	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
these	NULL
chimeric	NULL
transcription	NULL
factors	NULL
with	NULL
altered	NULL
structural	NULL
and	NULL
functional	NULL
features	NULL
would	NULL
play	NULL
a	NULL
substantial	NULL
role	NULL
in	NULL
the	NULL
leukemogenic	NULL
process	NULL
(	NULL
es	NULL
)	NULL
.	NULL

One	NULL
of	NULL
the	NULL
Â£E2A-involving	NULL
chimeric	NULL
molecules	NULL
,	NULL
E24-HLF	NULL
,	NULL
was	NULL
cloned	NULL
in	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
(	NULL
p22	NULL
;	NULL
q13	NULL
)	NULL
-bearing	NULL
childhood	NULL
ALL	NULL
with	NULL
pro-B	NULL
immuophenotype	NULL
.	NULL

``	NULL
*	NULL
Structurally	NULL
,	NULL
Â£2A-HLF	NULL
is	NULL
composed	NULL
of	NULL
the	NULL
trans-activation	NULL
domains	NULL
of	NULL
Â£24	NULL
and	NULL
the	NULL
DNA-binding	NULL
and	NULL
dimerization	NULL
domains	NULL
of	NULL
HLF	NULL
``	NULL
EZA	NULL
was	NULL
originally	NULL
identified	NULL
as	NULL
an	NULL
Ig	NULL
x	NULL
chain	NULL
enhancer-binding	NULL
protein	NULL
'	NULL
and	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
expressed	NULL
in	NULL
many	NULL
different	NULL
types	NULL
of	NULL
cells	NULL
.	NULL
``	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
HLF	NULL
is	NULL
normally	NULL
expressed	NULL
in	NULL
the	NULL
liver	NULL
,	NULL
kidney	NULL
,	NULL
and	NULL
lung	NULL
,	NULL
but	NULL
not	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL
``	NULL

Although	NULL
both	NULL
Â£E2A-HLF	NULL
and	NULL
HLF	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
same	NULL
consensus	NULL
sequence	NULL
,	NULL
5'-GTTACGTAAT-3	NULL
'	NULL
,	NULL
a	NULL
core	NULL
dyad-symmetric	NULL
motif	NULL
characteristic	NULL
of	NULL
bZIP	NULL
family	NULL
DNA-binding	NULL
proteins	NULL
,	NULL
``	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
E2A-HLF	NULL
and	NULL
HLF	NULL
possess	NULL
different	NULL
transcriptional	NULL
and	NULL
transforming	NULL
properties	NULL
.	NULL
``	NULL

''	NULL
Â£E2A-HLF	NULL
has	NULL
an	NULL
ability	NULL
to	NULL
transactivate	NULL
a	NULL
reporter	NULL
gene	NULL
in	NULL
various	NULL
types	NULL
of	NULL
cells	NULL
,	NULL
such	NULL
as	NULL
HepG2	NULL
hepatocellular	NULL
carcinoma	NULL
cells	NULL
,	NULL
NIH	NULL
3T3	NULL
fibroblasts	NULL
,	NULL
and	NULL
293	NULL
fetal	NULL
kidney	NULL
cells	NULL
,	NULL
whereas	NULL
transactivating	NULL
ability	NULL
of	NULL
wild-type	NULL
HLF	NULL
was	NULL
detected	NULL
only	NULL
in	NULL
293	NULL
cells	NULL
but	NULL
was	NULL
silent	NULL
in	NULL
HepG2	NULL
and	NULL
NIH	NULL
3T3	NULL
cells	NULL
.	NULL
``	NULL

In	NULL
addition	NULL
,	NULL
expression	NULL
of	NULL
Â£24-HLF	NULL
in	NULL
NIH	NULL
3T3	NULL
cells	NULL
induced	NULL
anchorage-independent	NULL
cell	NULL
growth	NULL
in	NULL
soft	NULL
agar	NULL
and	NULL
rendered	NULL
these	NULL
cells	NULL
tumorigenic	NULL
in	NULL
nude	NULL
mice	NULL
,	NULL
while	NULL
overexpression	NULL
of	NULL
HLF	NULL
has	NULL
not	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
oncogenic	NULL
.	NULL
``	NULL

A	NULL
subsequent	NULL
study	NULL
showed	NULL
that	NULL
Â£E2A-HLF	NULL
has	NULL
an	NULL
anti-apoptotic	NULL
effect	NULL
in	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
.	NULL
``	NULL

Introduction	NULL
of	NULL
a	NULL
dominant-negative	NULL
form	NULL
of	NULL
EZ2A-HLF	NULL
,	NULL
which	NULL
lacks	NULL
the	NULL
trans-activation	NULL
domains	NULL
of	NULL
Â£24	NULL
and	NULL
contains	NULL
a	NULL
defective	NULL
HLF	NULL
basic	NULL
domain	NULL
,	NULL
in	NULL
E2A-HLF-expressing	NULL
human	NULL
leukemic	NULL
cells	NULL
rapidly	NULL
induced	NULL
apoptosis	NULL
.	NULL
``	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
E2ZA-HLF	NULL
in	NULL
mouse	NULL
factor-dependent	NULL
Ba/F3	NULL
cells	NULL
blocked	NULL
factor-depleted-	NULL
and	NULL
radiation-induced	NULL
apoptosis	NULL
.	NULL
``	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
EZA-HLF	NULL
would	NULL
activate	NULL
genes	NULL
that	NULL
are	NULL
normally	NULL
quiescent	NULL
in	NULL
lymphoid	NULL
development	NULL
and	NULL
that	NULL
the	NULL
Blood	NULL
,	NULL
Vol	NULL
93	NULL
,	NULL
No	NULL
9	NULL
(	NULL
May	NULL
1	NULL
)	NULL
,	NULL
1999	NULL
;	NULL
pp	NULL
2780-2790	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

E2A-HLF	NULL
TRANSGENIC	NULL
MICE	NULL
aberrant	NULL
gene	NULL
expression	NULL
would	NULL
contribute	NULL
to	NULL
the	NULL
development	NULL
of	NULL
ALL	NULL
.	NULL

Although	NULL
these	NULL
studies	NULL
have	NULL
provided	NULL
us	NULL
with	NULL
insights	NULL
in	NULL
the	NULL
biological	NULL
properties	NULL
of	NULL
Â£E2A-HLF	NULL
,	NULL
the	NULL
in	NULL
vivo	NULL
role	NULL
of	NULL
E2A-HLF	NULL
in	NULL
lymphoid	NULL
development	NULL
and	NULL
leukemogenesis	NULL
has	NULL
not	NULL
been	NULL
fully	NULL
understood	NULL
.	NULL

To	NULL
address	NULL
this	NULL
issue	NULL
,	NULL
we	NULL
generated	NULL
and	NULL
analyzed	NULL
mice	NULL
expressing	NULL
E2A-HLF	NULL
in	NULL
cells	NULL
committed	NULL
to	NULL
the	NULL
lymphoid	NULL
lineage	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Construction	NULL
of	NULL
the	NULL
transgene	NULL
and	NULL
generation	NULL
of	NULL
the	NULL
transgenic	NULL
mice	NULL
.	NULL

The	NULL
E2A-HLF	NULL
cDNAÂ®	NULL
was	NULL
subcloned	NULL
into	NULL
an	NULL
expression	NULL
vector	NULL
which	NULL
contains	NULL
Ig	NULL
enhancer	NULL
and	NULL
promoter	NULL
as	NULL
regulatory	NULL
elements	NULL
.	NULL

A	NULL
fragment	NULL
encompassing	NULL
the	NULL
Ig	NULL
enhancer/promoter	NULL
,	NULL
the	NULL
Â£2A-HLF	NULL
cDNA	NULL
,	NULL
and	NULL
the	NULL
SV40	NULL
early	NULL
splicing	NULL
and	NULL
polyadenylation	NULL
signals	NULL
was	NULL
microinjected	NULL
into	NULL
pronuclei	NULL
of	NULL
eggs	NULL
from	NULL
C57BL/6XDBA/2	NULL
F2	NULL
mice	NULL
as	NULL
described	NULL
earlier	NULL
.	NULL
``	NULL

The	NULL
transgenic	NULL
mice	NULL
were	NULL
identified	NULL
by	NULL
hybridizing	NULL
tail	NULL
DNA	NULL
with	NULL
the	NULL
injected	NULL
fragment	NULL
``	NULL
and	NULL
the	NULL
transgenic	NULL
progeny	NULL
were	NULL
generated	NULL
by	NULL
successive	NULL
mating	NULL
of	NULL
the	NULL
founder	NULL
mice	NULL
or	NULL
transgenic	NULL
descendants	NULL
with	NULL
C57BL/6XDBA/2	NULL
F1	NULL
mice	NULL
.	NULL

The	NULL
mice	NULL
were	NULL
kept	NULL
under	NULL
a	NULL
conventional	NULL
maintaining	NULL
condition	NULL
or	NULL
in	NULL
a	NULL
separated	NULL
clean	NULL
isolator	NULL
.	NULL

Pathological	NULL
examination	NULL
.	NULL

-	NULL
After	NULL
gross	NULL
examination	NULL
,	NULL
all	NULL
the	NULL
tissues	NULL
were	NULL
fixed	NULL
in	NULL
10	NULL
%	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
-buffered	NULL
formalde-hyde	NULL
,	NULL
embedded	NULL
in	NULL
paraffin	NULL
,	NULL
and	NULL
stained	NULL
with	NULL
hematoxylin-eosin	NULL
(	NULL
HE	NULL
)	NULL
.	NULL

Smears	NULL
of	NULL
peripheral	NULL
blood	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
Wright-Giemsa	NULL
(	NULL
WG	NULL
)	NULL
.	NULL

Protein	NULL
extraction	NULL
,	NULL
immunoprecipitation	NULL
,	NULL
and	NULL
Western	NULL
blotting	NULL
.	NULL

-	NULL
Tissues	NULL
were	NULL
homogenized	NULL
in	NULL
RIPA	NULL
lysis	NULL
buffer	NULL
(	NULL
150	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
50	NULL
mmol/L	NULL
Tris-Cl	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
0.05	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
,	NULL
1	NULL
%	NULL
sodium	NULL
deoxycholate	NULL
)	NULL
with	NULL
50	NULL
U/mL	NULL
aprotinin	NULL
.	NULL

For	NULL
detecting	NULL
E2A-HLF	NULL
protein	NULL
,	NULL
1	NULL
mg	NULL
of	NULL
protein	NULL
aliquots	NULL
were	NULL
incubated	NULL
with	NULL
1:1,000	NULL
diluted	NULL
anti-Â£24	NULL
antibody	NULL
``	NULL
and	NULL
immunoprecipitated	NULL
proteins	NULL
were	NULL
probed	NULL
with	NULL
1:1,000	NULL
diluted	NULL
anti-HLF	NULL
antibody	NULL
.	NULL
``	NULL

The	NULL
positive	NULL
signals	NULL
were	NULL
visualized	NULL
using	NULL
the	NULL
ProtoBlot	NULL
Western	NULL
AP	NULL
system	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

Immunofluorescent	NULL
staining	NULL
.	NULL

|	NULL
Transgenic	NULL
spleens	NULL
were	NULL
fixed	NULL
in	NULL
10	NULL
%	NULL
PBS-buffered	NULL
formalin	NULL
and	NULL
embedded	NULL
in	NULL
paraffin	NULL
.	NULL

Specimens	NULL
were	NULL
mounted	NULL
on	NULL
saline-coated	NULL
slides	NULL
,	NULL
dewaxed	NULL
in	NULL
xylin	NULL
,	NULL
rehydrated	NULL
through	NULL
a	NULL
graded	NULL
series	NULL
of	NULL
alcohols	NULL
,	NULL
and	NULL
treated	NULL
with	NULL
20	NULL
ug/mL	NULL
proteinase	NULL
K	NULL
in	NULL
10	NULL
mmol/L	NULL
Tris-Cl	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
at	NULL
37Â°C	NULL
for	NULL
15	NULL
minutes	NULL
.	NULL

After	NULL
washing	NULL
two	NULL
times	NULL
with	NULL
PBS	NULL
,	NULL
specimens	NULL
were	NULL
stained	NULL
with	NULL
1:100	NULL
diluted	NULL
fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
-conjugated	NULL
anti-B220	NULL
monoclonal	NULL
antibody	NULL
(	NULL
MoAb	NULL
)	NULL
(	NULL
Pharmingen	NULL
,	NULL
Osaka	NULL
,	NULL
Japan	NULL
)	NULL
and	NULL
1:50	NULL
diluted	NULL
anti-HLF	NULL
poly-clonal	NULL
antibody	NULL
``	NULL
coupled	NULL
with	NULL
1:50	NULL
diluted	NULL
Texas-red-conjugated	NULL
anti-rabbit	NULL
antibody	NULL
(	NULL
Jackson	NULL
ImmunoResearch	NULL
Laboratories	NULL
Inc	NULL
,	NULL
West	NULL
Grove	NULL
,	NULL
PA	NULL
)	NULL
.	NULL

After	NULL
washing	NULL
three	NULL
times	NULL
with	NULL
PBS	NULL
,	NULL
specimens	NULL
were	NULL
observed	NULL
under	NULL
a	NULL
confocal	NULL
microscopic	NULL
system	NULL
,	NULL
MRC1024	NULL
(	NULL
BioRad	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Detection	NULL
of	NULL
apoptotic	NULL
cells	NULL
with	NULL
TdT-	NULL
mediated	NULL
dUTP	NULL
nick	NULL
end	NULL
labeling	NULL
(	NULL
TUNEL	NULL
)	NULL
.	NULL

Transgenic	NULL
and	NULL
nontransgenic	NULL
thymuses	NULL
were	NULL
fixed	NULL
in	NULL
10	NULL
%	NULL
PBS-buffered	NULL
formalin	NULL
and	NULL
embedded	NULL
in	NULL
paraffin	NULL
.	NULL

Specimens	NULL
mounted	NULL
on	NULL
saline-coated	NULL
slides	NULL
were	NULL
dewaxed	NULL
as	NULL
described	NULL
above	NULL
.	NULL

After	NULL
washing	NULL
two	NULL
times	NULL
with	NULL
PBS	NULL
,	NULL
specimens	NULL
were	NULL
subjected	NULL
to	NULL
TUNEL	NULL
reaction	NULL
using	NULL
in	NULL
situ	NULL
cell	NULL
death	NULL
detection	NULL
kit	NULL
(	NULL
Boehringer	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
and	NULL
were	NULL
observed	NULL
under	NULL
a	NULL
confocal	NULL
microscopic	NULL
system	NULL
,	NULL
MRC1024	NULL
(	NULL
BioRad	NULL
)	NULL
.	NULL

Flow	NULL
cytometric	NULL
analysis	NULL
.	NULL

-	NULL
Cells	NULL
were	NULL
stained	NULL
with	NULL
FITC-	NULL
or	NULL
phyco-erythrin-conjugated	NULL
commercial	NULL
MoAbs	NULL
including	NULL
anti-Thy-1.2	NULL
,	NULL
anti-B220	NULL
,	NULL
anti-CD4	NULL
,	NULL
anti-CD8	NULL
,	NULL
and	NULL
anti-CD43	NULL
(	NULL
Pharmingen	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

The	NULL
stained	NULL
cells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
PBS	NULL
and	NULL
analyzed	NULL
on	NULL
a	NULL
FACScan	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

2781	NULL
Colony	NULL
assays	NULL
.	NULL

-	NULL
Bone	NULL
marrow	NULL
cells	NULL
of	NULL
transgenic	NULL
mice	NULL
and	NULL
nontransgenic	NULL
littermates	NULL
were	NULL
subjected	NULL
to	NULL
the	NULL
in	NULL
vitro	NULL
colony	NULL
formation	NULL
assays	NULL
as	NULL
described	NULL
elsewhere	NULL
.	NULL

'*	NULL
RNA	NULL
extraction	NULL
and	NULL
reverse	NULL
transcription-polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
RT-PCR	NULL
)	NULL
.	NULL

|	NULL
Total	NULL
RNA	NULL
was	NULL
extracted	NULL
using	NULL
the	NULL
acid	NULL
guanidine/phenol-chloroform	NULL
method	NULL
.	NULL
``	NULL

''	NULL
The	NULL
RT	NULL
and	NULL
PCR	NULL
amplification	NULL
reactions	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
detailed	NULL
.	NULL
``	NULL

RESULTS	NULL
Expression	NULL
of	NULL
the	NULL
E2A-HLF	NULL
transgene	NULL
product	NULL
in	NULL
T	NULL
and	NULL
B	NULL
lymphocytes	NULL
in	NULL
the	NULL
transgenic	NULL
mice	NULL
.	NULL

-	NULL
We	NULL
planned	NULL
to	NULL
generate	NULL
transgenic	NULL
mice	NULL
expressing	NULL
EZ2A-HLF	NULL
in	NULL
hematopoietic	NULL
cells	NULL
committed	NULL
to	NULL
the	NULL
lymphoid	NULL
lineage	NULL
.	NULL

With	NULL
this	NULL
aim	NULL
,	NULL
Ig	NULL
enhancer	NULL
and	NULL
promoter	NULL
were	NULL
chosen	NULL
as	NULL
regulatory	NULL
elements	NULL
.	NULL

The	NULL
schematic	NULL
model	NULL
of	NULL
the	NULL
transgene	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
1A	NULL
.	NULL

Microinjec-tion	NULL
resulted	NULL
in	NULL
generation	NULL
of	NULL
three	NULL
founder	NULL
mice	NULL
containing	NULL
approximately	NULL
10	NULL
copies	NULL
of	NULL
the	NULL
transgene	NULL
in	NULL
a	NULL
head-to-tail	NULL
manner	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
two	NULL
of	NULL
these	NULL
three	NULL
founders	NULL
(	NULL
named	NULL
1-17	NULL
and	NULL
2-17	NULL
)	NULL
transmitted	NULL
the	NULL
transgene	NULL
stably	NULL
to	NULL
their	NULL
progeny	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
transgene	NULL
product	NULL
in	NULL
the	NULL
lymphoid	NULL
tissues	NULL
,	NULL
proteins	NULL
extracted	NULL
from	NULL
the	NULL
thymus	NULL
and	NULL
the	NULL
spleen	NULL
of	NULL
a	NULL
transgenic	NULL
mouse	NULL
and	NULL
a	NULL
nontransgenic	NULL
littermate	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-Â£24	NULL
antibody	NULL
and	NULL
immunoprecipitated	NULL
proteins	NULL
were	NULL
blotted	NULL
with	NULL
anti-HLF	NULL
antibody	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
1B	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
EZA-HLF	NULL
protein	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
thymus	NULL
but	NULL
was	NULL
undetectable	NULL
in	NULL
the	NULL
spleen	NULL
in	NULL
both	NULL
lines	NULL
,	NULL
raising	NULL
a	NULL
question	NULL
of	NULL
whether	NULL
B	NULL
lymphocytes	NULL
expressed	NULL
the	NULL
EZA-HLF	NULL
transgene	NULL
product	NULL
.	NULL

To	NULL
address	NULL
this	NULL
issue	NULL
,	NULL
we	NULL
performed	NULL
immunofluorescent	NULL
staining	NULL
of	NULL
the	NULL
transgenic	NULL
spleen	NULL
using	NULL
FITC-conjugated	NULL
anti-B220	NULL
antibody	NULL
and	NULL
anti-HLF	NULL
antibody	NULL
coupled	NULL
with	NULL
Texas-red-conjugated	NULL
anti-rabbit	NULL
antibody	NULL
.	NULL

The	NULL
results	NULL
showed	NULL
that	NULL
cells	NULL
expressing	NULL
B220	NULL
were	NULL
positive	NULL
for	NULL
HLF	NULL
(	NULL
Fig	NULL
1C	NULL
)	NULL
.	NULL

Because	NULL
HLF	NULL
has	NULL
not	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
expressed	NULL
in	NULL
the	NULL
hematopoietic	NULL
cells	NULL
,	NULL
``	NULL
HLF*	NULL
lymphocytes	NULL
are	NULL
considered	NULL
to	NULL
express	NULL
Â£2A-HLF	NULL
protein	NULL
.	NULL

These	NULL
results	NULL
showed	NULL
that	NULL
both	NULL
T	NULL
and	NULL
B	NULL
lymphocytes	NULL
expressed	NULL
the	NULL
E2A-HLF	NULL
transgene	NULL
product	NULL
in	NULL
the	NULL
transgenic	NULL
mice	NULL
.	NULL

E2A-HLF	NULL
transgenic	NULL
mice	NULL
were	NULL
susceptible	NULL
to	NULL
infection	NULL
.	NULL

The	NULL
transgenic	NULL
mice	NULL
were	NULL
initially	NULL
kept	NULL
under	NULL
a	NULL
conventional	NULL
maintaining	NULL
condition	NULL
.	NULL

Under	NULL
this	NULL
condition	NULL
,	NULL
although	NULL
the	NULL
transgenic	NULL
mice	NULL
grew	NULL
normally	NULL
until	NULL
weaning	NULL
(	NULL
4	NULL
weeks	NULL
of	NULL
age	NULL
)	NULL
,	NULL
they	NULL
gradually	NULL
exhibited	NULL
emaciation	NULL
and	NULL
almost	NULL
all	NULL
the	NULL
transgenic	NULL
mice	NULL
died	NULL
within	NULL
several	NULL
months	NULL
after	NULL
birth	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
fact	NULL
that	NULL
no	NULL
nontransgenic	NULL
littermates	NULL
died	NULL
within	NULL
the	NULL
same	NULL
period	NULL
.	NULL

Autopsies	NULL
of	NULL
the	NULL
dead	NULL
animals	NULL
showed	NULL
abscesses	NULL
,	NULL
strongly	NULL
suggesting	NULL
that	NULL
the	NULL
transgenic	NULL
mice	NULL
were	NULL
susceptible	NULL
to	NULL
infection	NULL
.	NULL

To	NULL
address	NULL
this	NULL
issue	NULL
,	NULL
newly	NULL
weaned	NULL
transgenic	NULL
and	NULL
nontransgenic	NULL
littermates	NULL
(	NULL
4	NULL
weeks	NULL
of	NULL
age	NULL
)	NULL
were	NULL
divided	NULL
into	NULL
two	NULL
groups	NULL
and	NULL
mice	NULL
in	NULL
one	NULL
group	NULL
were	NULL
kept	NULL
under	NULL
the	NULL
same	NULL
conventional	NULL
condition	NULL
,	NULL
whereas	NULL
mice	NULL
in	NULL
the	NULL
other	NULL
group	NULL
were	NULL
maintained	NULL
in	NULL
a	NULL
separated	NULL
clean	NULL
isolator	NULL
.	NULL

As	NULL
a	NULL
result	NULL
of	NULL
about	NULL
3	NULL
months	NULL
of	NULL
observation	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
transgenic	NULL
mice	NULL
that	NULL
grew	NULL
under	NULL
the	NULL
conventional	NULL
condition	NULL
also	NULL
showed	NULL
a	NULL
high	NULL
mortality	NULL
rate	NULL
(	NULL
5	NULL
of	NULL
17	NULL
transgenic	NULL
mice	NULL
were	NULL
alive	NULL
more	NULL
than	NULL
4	NULL
months	NULL
of	NULL
age	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
transgenic	NULL
mice	NULL
that	NULL
grew	NULL
in	NULL
a	NULL
clean	NULL
isolator	NULL
exhibited	NULL
much	NULL
better	NULL
surviving	NULL
rate	NULL
(	NULL
14	NULL
of	NULL
16	NULL
transgenic	NULL
mice	NULL
are	NULL
surviving	NULL
over	NULL
4	NULL
months	NULL
of	NULL
age	NULL
)	NULL
(	NULL
Fig	NULL
2	NULL
,	NULL
right	NULL
)	NULL
.	NULL

During	NULL
this	NULL
period	NULL
,	NULL
no	NULL
nontransgenic	NULL
mice	NULL
died	NULL
under	NULL
either	NULL
condition	NULL
(	NULL
Fig	NULL
2	NULL
,	NULL
left	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
cause	NULL
of	NULL
the	NULL
death	NULL
of	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2782	NULL
HONDA	NULL
ET	NULL
AL	NULL
Ig	NULL
SV40	NULL
enhancer	NULL
E2A-HLF	NULL
cDNA	NULL
splicing	NULL
and	NULL
promoter	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
signal	NULL
___	NULL
:	NULL
>	NULL
-	NULL
Â»	NULL
+	NULL
<	NULL
?	NULL

P1	NULL
P3	NULL
P4	NULL
P2	NULL
icing	NULL
PO	NULL
'	NULL
Y	NULL
(	NULL
A	NULL
)	NULL
splicing	NULL
signal	NULL
1	NULL
Kb	NULL
B	NULL
thymus	NULL
-	NULL
spleen	NULL
I	NULL
-I	NULL
x\_x\	NULL
A	NULL
_	NULL
(	NULL
Kd	NULL
)	NULL
0\	NULL
``	NULL
v0	NULL
â	NULL
\	NULL
``	NULL
v	NULL
66	NULL
E2A-HLF	NULL
-	NULL
Â»	NULL
ig	NULL
-	NULL
Â»	NULL
45	NULL
the	NULL
transgenic	NULL
mice	NULL
,	NULL
tissues	NULL
of	NULL
the	NULL
dead	NULL
or	NULL
moribund	NULL
mice	NULL
were	NULL
pathologically	NULL
examined	NULL
.	NULL

In	NULL
about	NULL
half	NULL
of	NULL
the	NULL
mice	NULL
examined	NULL
,	NULL
macroscopic	NULL
abscesses	NULL
were	NULL
found	NULL
in	NULL
several	NULL
major	NULL
organs	NULL
such	NULL
as	NULL
the	NULL
liver	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
intestine	NULL
.	NULL

Microabscesses	NULL
were	NULL
detected	NULL
in	NULL
all	NULL
the	NULL
cases	NULL
and	NULL
were	NULL
accompanied	NULL
by	NULL
tissue	NULL
necrosis	NULL
and	NULL
infiltration	NULL
of	NULL
granulocytes	NULL
.	NULL

Staining	NULL
of	NULL
stamp	NULL
specimens	NULL
of	NULL
the	NULL
abscesses	NULL
showed	NULL
proliferation	NULL
of	NULL
bacteria	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
transgenic	NULL
mice	NULL
were	NULL
susceptible	NULL
to	NULL
infection	NULL
and	NULL
that	NULL
the	NULL
major	NULL
cause	NULL
of	NULL
early	NULL
death	NULL
of	NULL
the	NULL
transgenic	NULL
mice	NULL
was	NULL
bacterial	NULL
infection	NULL
.	NULL

Decrease	NULL
in	NULL
thymocytes	NULL
and	NULL
marked	NULL
reduction	NULL
in	NULL
splenic	NULL
lymphocytes	NULL
in	NULL
EZA-HLE	NULL
transgenic	NULL
mice	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
the	NULL
expression	NULL
of	NULL
E2A-HLF	NULL
affected	NULL
the	NULL
development	NULL
of	NULL
the	NULL
lymphoid	NULL
tissues	NULL
,	NULL
transgenic	NULL
mice	NULL
and	NULL
nontransgenic	NULL
(	NULL
%	NULL
)	NULL
(	NULL
%	NULL
)	NULL
o	NULL
(	NULL
n=15	NULL
)	NULL
_	NULL
109	NULL
=============iM=l3	NULL
)	NULL
100	NULL
--	NULL
--	NULL
(	NULL
n=16	NULL
)	NULL
so	NULL
-	NULL
80	NULL
7	NULL
m	NULL
so-	NULL
eo	NULL
2	NULL
2	NULL
40	NULL
-	NULL
ao	NULL
ir	NULL
(	NULL
n=17	NULL
)	NULL
20	NULL
-	NULL
20	NULL
4	NULL
0	NULL
-f	NULL
--	NULL
-	NULL
0	NULL
4	NULL
o	NULL
eo	NULL
120	NULL
o	NULL
so	NULL
120	NULL
(	NULL
days	NULL
)	NULL
Age	NULL
Fig	NULL
2	NULL
.	NULL

-	NULL
Survival	NULL
curves	NULL
of	NULL
transgenic	NULL
mice	NULL
(	NULL
Tg	NULL
,	NULL
right	NULL
)	NULL
and	NULL
nontransgenic	NULL
controls	NULL
(	NULL
C	NULL
,	NULL
left	NULL
)	NULL
that	NULL
are	NULL
kept	NULL
under	NULL
a	NULL
conventional	NULL
condition	NULL
(	NULL
solid	NULL
lines	NULL
)	NULL
or	NULL
in	NULL
a	NULL
clean	NULL
isolator	NULL
(	NULL
dotted	NULL
lines	NULL
)	NULL
.	NULL

The	NULL
life	NULL
span	NULL
is	NULL
presented	NULL
by	NULL
the	NULL
Kaplan-Meier	NULL
method	NULL
.	NULL

Fig	NULL
1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
model	NULL
of	NULL
the	NULL
injection	NULL
fragment	NULL
for	NULL
generating	NULL
E2A-HLF	NULL
transgenic	NULL
mice	NULL
.	NULL

The	NULL
Ig	NULL
enhancer/	NULL
promoter	NULL
,	NULL
the	NULL
E24-HLFcDNA	NULL
,	NULL
and	NULL
the	NULL
SV40	NULL
early	NULL
splicing	NULL
and	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
signals	NULL
are	NULL
shown	NULL
as	NULL
white	NULL
,	NULL
black	NULL
,	NULL
and	NULL
shaded	NULL
boxes	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
primers	NULL
used	NULL
for	NULL
RT-PCR	NULL
(	NULL
P1-P4	NULL
)	NULL
are	NULL
also	NULL
indicated	NULL
.	NULL

The	NULL
bar	NULL
shows	NULL
1	NULL
kb	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
E2A-HLF	NULL
transgene	NULL
product	NULL
in	NULL
the	NULL
thymus	NULL
and	NULL
spleen	NULL
of	NULL
a	NULL
control	NULL
mouse	NULL
(	NULL
C	NULL
)	NULL
and	NULL
a	NULL
transgenic	NULL
mouse	NULL
from	NULL
two	NULL
independent	NULL
lines	NULL
(	NULL
1-17	NULL
and	NULL
2-17	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
E2A-HLF	NULL
protein	NULL
and	NULL
Ig	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
,	NULL
and	NULL
the	NULL
positions	NULL
of	NULL
the	NULL
molecular	NULL
marker	NULL
are	NULL
show	NULL
n	NULL
on	NULL
the	NULL
left	NULL
.	NULL

littermates	NULL
at	NULL
4	NULL
weeks	NULL
of	NULL
age	NULL
were	NULL
autopsied	NULL
and	NULL
macroscopi-cally	NULL
examined	NULL
.	NULL

Consistent	NULL
and	NULL
remarkable	NULL
changes	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
thymus	NULL
and	NULL
in	NULL
the	NULL
spleen	NULL
.	NULL

The	NULL
thymuses	NULL
of	NULL
the	NULL
transgenic	NULL
mice	NULL
were	NULL
apparently	NULL
smaller	NULL
than	NULL
those	NULL
of	NULL
the	NULL
nontransgenic	NULL
littermates	NULL
.	NULL

The	NULL
spleens	NULL
of	NULL
the	NULL
transgenic	NULL
mice	NULL
were	NULL
consistently	NULL
larger	NULL
than	NULL
those	NULL
of	NULL
the	NULL
nontransgenic	NULL
litter	NULL
mates	NULL
.	NULL

The	NULL
representative	NULL
macroscopic	NULL
appearances	NULL
of	NULL
a	NULL
transgenic	NULL
mouse	NULL
and	NULL
a	NULL
nontransgenic	NULL
littermate	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
3	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
histological	NULL
changes	NULL
underlying	NULL
the	NULL
phenotypic	NULL
abnormalities	NULL
,	NULL
the	NULL
thymuses	NULL
and	NULL
spleens	NULL
of	NULL
transgenic	NULL
mice	NULL
and	NULL
nontransgenic	NULL
littermates	NULL
at	NULL
4	NULL
weeks	NULL
of	NULL
age	NULL
were	NULL
subjected	NULL
to	NULL
microscopic	NULL
examination	NULL
.	NULL

Significant	NULL
changes	NULL
were	NULL
observed	NULL
in	NULL
the	NULL
medulla	NULL
of	NULL
the	NULL
thymus	NULL
and	NULL
in	NULL
the	NULL
white	NULL
pulps	NULL
of	NULL
the	NULL
spleen	NULL
.	NULL

In	NULL
comparison	NULL
with	NULL
the	NULL
nontransgenic	NULL
thymus	NULL
,	NULL
the	NULL
transgenic	NULL
thymus	NULL
showed	NULL
enlargement	NULL
of	NULL
the	NULL
medulla	NULL
,	NULL
and	NULL
obscurity	NULL
and	NULL
irregularity	NULL
of	NULL
the	NULL
medulla/cortex	NULL
junction	NULL
(	NULL
Fig	NULL
4A	NULL
,	NULL
top	NULL
panels	NULL
)	NULL
.	NULL

The	NULL
medulla	NULL
of	NULL
the	NULL
transgenic	NULL
thymus	NULL
contained	NULL
small	NULL
numbers	NULL
of	NULL
lymphoid	NULL
cells	NULL
and	NULL
consisted	NULL
mainly	NULL
of	NULL
epithelial	NULL
cells	NULL
and	NULL
interdigitating	NULL
cells	NULL
.	NULL

Infiltration	NULL
of	NULL
neutro-phils	NULL
,	NULL
multinucleated	NULL
giant	NULL
cells	NULL
,	NULL
and	NULL
tingeble-body	NULL
macrophages	NULL
were	NULL
frequently	NULL
seen	NULL
(	NULL
Fig	NULL
4A	NULL
,	NULL
bottom	NULL
panels	NULL
)	NULL
.	NULL

As	NULL
for	NULL
the	NULL
spleen	NULL
,	NULL
the	NULL
fundamental	NULL
structure	NULL
of	NULL
the	NULL
spleen	NULL
(	NULL
integrity	NULL
of	NULL
white	NULL
and	NULL
red	NULL
pulps	NULL
)	NULL
was	NULL
disorganized	NULL
in	NULL
the	NULL
transgenic	NULL
mice	NULL
in	NULL
comparison	NULL
with	NULL
the	NULL
nontransgenic	NULL
littermates	NULL
(	NULL
Fig	NULL
4B	NULL
,	NULL
top	NULL
panels	NULL
)	NULL
.	NULL

The	NULL
periarteriolar	NULL
lymphoid	NULL
sheaths	NULL
in	NULL
the	NULL
transgenic	NULL
spleen	NULL
were	NULL
irregularly	NULL
shaped	NULL
where	NULL
lymphoid	NULL
cells	NULL
were	NULL
markedly	NULL
depleted	NULL
and	NULL
neutrophils	NULL
and	NULL
megakaryocytes	NULL
infiltrated	NULL
(	NULL
Fig	NULL
4B	NULL
,	NULL
bottom	NULL
panels	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
showed	NULL
that	NULL
the	NULL
thymic	NULL
regression	NULL
was	NULL
due	NULL
to	NULL
decrease	NULL
in	NULL
thymocyte	NULL
number	NULL
and	NULL
that	NULL
the	NULL
splenic	NULL
enlargement	NULL
was	NULL
associated	NULL
with	NULL
marked	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

C	NULL
anti-B220	NULL
anti-HLF	NULL
Fig	NULL
1	NULL
.	NULL

(	NULL
Cont	NULL
'd	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Immunofluorescent	NULL
staining	NULL
of	NULL
the	NULL
transgenic	NULL
spleen	NULL
with	NULL
anti-B220	NULL
and	NULL
anti-HLF	NULL
antibodies	NULL
.	NULL

The	NULL
B220-expressing	NULL
and	NULL
HLFexpressing	NULL
cells	NULL
are	NULL
visualized	NULL
by	NULL
green	NULL
and	NULL
red	NULL
signals	NULL
,	NULL
Fig	NULL
3	NULL
.	NULL

-	NULL
Macroscopic	NULL
appearances	NULL
of	NULL
a	NULL
transgenic	NULL
mouse	NULL
(	NULL
Tg	NULL
)	NULL
and	NULL
a	NULL
respectively	NULL
.	NULL

nontransgenic	NULL
control	NULL
(	NULL
C	NULL
)	NULL
(	NULL
4	NULL
weeks	NULL
of	NULL
age	NULL
)	NULL
.	NULL

The	NULL
thymuses	NULL
and	NULL
spleens	NULL
are	NULL
indicated	NULL
by	NULL
(	NULL
A	NULL
)	NULL
and	NULL
(	NULL
A	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
transgenic	NULL
mouse	NULL
exhibits	NULL
regressed	NULL
thymus	NULL
and	NULL
enlarged	NULL
spleen	NULL
.	NULL

a	NULL
oie	NULL
We	NULL
Toren	NULL
M	NULL
â	NULL
H	NULL
â	NULL
l-	NULL
168	NULL
;	NULL
Fig	NULL
4	NULL
.	NULL

HE-stained	NULL
sections	NULL
of	NULL
the	NULL
thymus	NULL
(	NULL
A	NULL
)	NULL
and	NULL
spleen	NULL
(	NULL
B	NULL
)	NULL
of	NULL
a	NULL
transgenic	NULL
mouse	NULL
(	NULL
Tg	NULL
)	NULL
and	NULL
a	NULL
nontransgenic	NULL
control	NULL
(	NULL
C	NULL
)	NULL
(	NULL
4	NULL
weeks	NULL
of	NULL
age	NULL
)	NULL
.	NULL

The	NULL
boxed	NULL
areas	NULL
in	NULL
the	NULL
top	NULL
panels	NULL
are	NULL
magnified	NULL
in	NULL
the	NULL
bottom	NULL
panels	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Thymus	NULL
.	NULL

In	NULL
the	NULL
lower	NULL
magnification	NULL
(	NULL
top	NULL
panels	NULL
)	NULL
,	NULL
transgenic	NULL
thymus	NULL
shows	NULL
enlargement	NULL
of	NULL
the	NULL
medulla	NULL
and	NULL
obscurity	NULL
and	NULL
irregularity	NULL
of	NULL
the	NULL
medulla/	NULL
cortex	NULL
junction	NULL
.	NULL

In	NULL
the	NULL
higher	NULL
magnification	NULL
(	NULL
bottom	NULL
panels	NULL
)	NULL
,	NULL
the	NULL
medulla	NULL
of	NULL
the	NULL
transgenic	NULL
thymus	NULL
contains	NULL
few	NULL
er	NULL
thymocytes	NULL
and	NULL
consists	NULL
of	NULL
epithelial	NULL
and	NULL
interdigitating	NULL
cells	NULL
.	NULL

Infiltrated	NULL
neutrophils	NULL
and	NULL
multi-	NULL
5	NULL
``	NULL
ets	NULL
.	NULL

nucleated	NULL
giant	NULL
cells	NULL
are	NULL
indicated	NULL
by	NULL
black	NULL
and	NULL
Â£igfa	NULL
{	NULL
Faxing	NULL
``	NULL
ara	NULL
Z	NULL
W	NULL
ï¬g	NULL
af	NULL
â	NULL
if	NULL
â	NULL
;	NULL
y	NULL
white	NULL
triangles	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
the	NULL
tingeble-body	NULL
_	NULL
|	NULL
j	NULL
ay	NULL
t	NULL
ke	NULL
L-	NULL
Â®	NULL
;	NULL
f	NULL
macrophages	NULL
are	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Spleen	NULL
.	NULL

-	NULL
,	NULL
.	NULL

aat	NULL
al..	NULL
h	NULL
seran	NULL
/	NULL
+2	NULL
;	NULL
3	NULL
In	NULL
the	NULL
lower	NULL
magnification	NULL
(	NULL
top	NULL
panels	NULL
)	NULL
,	NULL
transgenic	NULL
spleen	NULL
shows	NULL
marked	NULL
disorganization	NULL
in	NULL
the	NULL
fundamental	NULL
structures	NULL
.	NULL

In	NULL
the	NULL
higher	NULL
magnification	NULL
(	NULL
bottom	NULL
panels	NULL
)	NULL
,	NULL
in	NULL
a	NULL
w	NULL
hite	NULL
pulp	NULL
of	NULL
the	NULL
transgenic	NULL
spleen	NULL
,	NULL
lymphocytes	NULL
are	NULL
markedly	NULL
reduced	NULL
and	NULL
proliferation	NULL
of	NULL
neutrophils	NULL
and	NULL
megakaryocytes	NULL
is	NULL
observed	NULL
.	NULL

The	NULL
central	NULL
splenic	NULL
artery	NULL
,	NULL
which	NULL
is	NULL
located	NULL
in	NULL
the	NULL
middle	NULL
of	NULL
the	NULL
white	NULL
pulp	NULL
,	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2784	NULL
J	NULL
>	NULL
spleen	NULL
C	NULL
Tg	NULL
HONDA	NULL
ET	NULL
AL	NULL
%	NULL
hut	NULL
a	NULL
mk	NULL
Pal	NULL
ma	NULL
â	NULL
:	NULL
â	NULL
21	NULL
;	NULL
A|	NULL
t	NULL
B	NULL
o	NULL
F5	NULL
?	NULL

FE	NULL
:	NULL
a	NULL
;	NULL
5	NULL
,	NULL
710Â°	NULL
10	NULL
)	NULL
102	NULL
10Â°	NULL
10+	NULL
710Â°	NULL
10	NULL
)	NULL
10Â°	NULL
10Â°	NULL
10+	NULL
--	NULL
p	NULL
P	NULL
bone	NULL
marrow	NULL
t	NULL
C	NULL
hos	NULL
Tg	NULL
o	NULL
o	NULL
:	NULL
m	NULL
MCI	NULL
â	NULL
;	NULL
ME	NULL
â	NULL
;	NULL
o	NULL
|	NULL
Â°	NULL
:	NULL
=	NULL
3	NULL
o	NULL
I	NULL
m	NULL
,	NULL
4	NULL
an	NULL
;	NULL
-	NULL
aï¬	NULL
/g	NULL
<	NULL
gorrme	NULL
remy	NULL
gormmny	NULL
-g-rrme	NULL
Fig	NULL
6	NULL
.	NULL

Flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
the	NULL
spleen	NULL
(	NULL
A	NULL
)	NULL
1an	NULL
10	NULL
â	NULL
32	NULL
103	NULL
10+	NULL
ï¬nd	NULL
10	NULL
'	NULL
â	NULL
32	NULL
``	NULL
33	NULL
10+	NULL
and	NULL
bone	NULL
marrow	NULL
(	NULL
B	NULL
)	NULL
of	NULL
a	NULL
transgenic	NULL
mouse	NULL
(	NULL
Tg	NULL
)	NULL
and	NULL
--	NULL
-	NULL
Â»	NULL
B220	NULL
depletion	NULL
of	NULL
splenic	NULL
lymphocytes	NULL
and	NULL
diffuse	NULL
proliferation	NULL
of	NULL
other	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Increased	NULL
thymocyte	NULL
apoptosis	NULL
in	NULL
E2A-HLF	NULL
transgenic	NULL
mice	NULL
.	NULL

The	NULL
decrease	NULL
in	NULL
thymocyte	NULL
number	NULL
is	NULL
suggestive	NULL
of	NULL
either	NULL
reduction	NULL
of	NULL
thymocyte	NULL
production	NULL
or	NULL
alteration	NULL
in	NULL
thymocyte	NULL
survival	NULL
.	NULL

The	NULL
pathological	NULL
findings	NULL
that	NULL
the	NULL
thymocyte	NULL
decrease	NULL
was	NULL
associated	NULL
with	NULL
macrophage	NULL
infiltration	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
latter	NULL
possibility	NULL
.	NULL

To	NULL
confirm	NULL
this	NULL
,	NULL
the	NULL
thymuses	NULL
of	NULL
transgenic	NULL
mice	NULL
and	NULL
nontransgenic	NULL
littermates	NULL
were	NULL
subjected	NULL
to	NULL
TUNEL	NULL
staining	NULL
,	NULL
which	NULL
detects	NULL
apoptotic	NULL
cells	NULL
by	NULL
in	NULL
situ	NULL
labeling	NULL
using	NULL
TdT	NULL
and	NULL
dUTP	NULL
.	NULL
``	NULL

''	NULL
As	NULL
shown	NULL
in	NULL
Fig	NULL
5	NULL
(	NULL
see	NULL
page	NULL
2785	NULL
)	NULL
,	NULL
the	NULL
number	NULL
of	NULL
positively	NULL
stained	NULL
cells	NULL
was	NULL
significantly	NULL
increased	NULL
in	NULL
the	NULL
transgenic	NULL
thymus	NULL
in	NULL
comparison	NULL
with	NULL
the	NULL
nontransgenic	NULL
thymus	NULL
,	NULL
showing	NULL
that	NULL
the	NULL
decrease	NULL
in	NULL
thymocyte	NULL
number	NULL
was	NULL
caused	NULL
by	NULL
increased	NULL
apoptosis	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
the	NULL
thymocyte	NULL
apoptosis	NULL
was	NULL
due	NULL
to	NULL
a	NULL
differentiation	NULL
block	NULL
at	NULL
a	NULL
specific	NULL
developmental	NULL
stage	NULL
,	NULL
the	NULL
transgenic	NULL
thymocytes	NULL
were	NULL
subjected	NULL
to	NULL
flow	NULL
cytometric	NULL
analysis	NULL
using	NULL
anti-CD4	NULL
and	NULL
anti-CD8	NULL
antibodies	NULL
.	NULL

Repeated	NULL
experiments	NULL
showed	NULL
that	NULL
the	NULL
percentage	NULL
of	NULL
each	NULL
CD4/CD8	NULL
subset	NULL
(	NULL
CD4-/CD8~	NULL
,	NULL
CD4+*/	NULL
CD8+	NULL
,	NULL
CD4*/CD8~	NULL
,	NULL
and	NULL
CD4-CD8*	NULL
)	NULL
was	NULL
not	NULL
significantly	NULL
a	NULL
nontransgenic	NULL
control	NULL
(	NULL
C	NULL
)	NULL
with	NULL
B220	NULL
and	NULL
anti-CD43	NULL
antibodies	NULL
(	NULL
4	NULL
weeks	NULL
of	NULL
age	NULL
)	NULL
.	NULL

The	NULL
transgenic	NULL
spleen	NULL
and	NULL
bone	NULL
marrow	NULL
show	NULL
marked	NULL
reduction	NULL
of	NULL
both	NULL
B220+	NULL
CD43+	NULL
and	NULL
B220+	NULL
CD43~	NULL
populations	NULL
.	NULL

altered	NULL
between	NULL
the	NULL
transgenic	NULL
and	NULL
nontransgenic	NULL
thymuses	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
E2A-HLF	NULL
induced	NULL
thymocyte	NULL
apoptosis	NULL
with	NULL
no	NULL
obvious	NULL
interference	NULL
in	NULL
thymocyte	NULL
differentiation	NULL
.	NULL

Maturation	NULL
block	NULL
of	NULL
B-cell	NULL
progenitors	NULL
in	NULL
E2A-HLF	NULL
transgenic	NULL
mice	NULL
.	NULL

-	NULL
The	NULL
pathological	NULL
analysis	NULL
of	NULL
the	NULL
transgenic	NULL
spleen	NULL
showed	NULL
a	NULL
marked	NULL
decrease	NULL
in	NULL
splenic	NULL
lymphocytes	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
strongly	NULL
suggest	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
E2A-HLF	NULL
impaired	NULL
B-cell	NULL
development	NULL
as	NULL
well	NULL
as	NULL
induced	NULL
T-cell	NULL
apoptosis	NULL
.	NULL

To	NULL
address	NULL
this	NULL
possibility	NULL
and	NULL
to	NULL
identify	NULL
the	NULL
stages	NULL
in	NULL
which	NULL
the	NULL
B-cell	NULL
development	NULL
was	NULL
impaired	NULL
,	NULL
splenic	NULL
and	NULL
bone	NULL
marrow	NULL
cells	NULL
of	NULL
the	NULL
transgenic	NULL
mice	NULL
and	NULL
nontransgenic	NULL
litter	NULL
mates	NULL
were	NULL
subjected	NULL
to	NULL
flow	NULL
cytometric	NULL
analysis	NULL
with	NULL
anti-B220	NULL
and	NULL
anti-CD43	NULL
antibodies	NULL
.	NULL

The	NULL
B220+*	NULL
CD43*	NULL
population	NULL
contains	NULL
mainly	NULL
early	NULL
B-cell	NULL
progenitors	NULL
,	NULL
whereas	NULL
B220+*	NULL
CD43~	NULL
population	NULL
consists	NULL
of	NULL
pre-B	NULL
and	NULL
mature	NULL
B	NULL
lympho-cytes	NULL
.	NULL
``	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
6A	NULL
and	NULL
B	NULL
,	NULL
significant	NULL
changes	NULL
were	NULL
observed	NULL
in	NULL
the	NULL
B220+*	NULL
CD43*	NULL
as	NULL
well	NULL
as	NULL
the	NULL
B220+	NULL
CD43~	NULL
population	NULL
both	NULL
in	NULL
the	NULL
spleen	NULL
and	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
.	NULL

The	NULL
nontransgenic	NULL
spleen	NULL
and	NULL
bone	NULL
marrow	NULL
contained	NULL
approximately	NULL
6	NULL
%	NULL
to	NULL
10	NULL
%	NULL
of	NULL
B220+*	NULL
CD43*	NULL
cells	NULL
,	NULL
whereas	NULL
only	NULL
2	NULL
%	NULL
to	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

E2A-HLF	NULL
TRANSGENIC	NULL
MICE	NULL
Fig	NULL
5	NULL
.	NULL

TUNEL	NULL
staining	NULL
of	NULL
the	NULL
thymus	NULL
of	NULL
a	NULL
transgenic	NULL
mouse	NULL
(	NULL
Tg	NULL
)	NULL
and	NULL
a	NULL
nontransgenic	NULL
control	NULL
(	NULL
C	NULL
)	NULL
(	NULL
4	NULL
weeks	NULL
of	NULL
age	NULL
)	NULL
.	NULL

Apoptotic	NULL
thymocytes	NULL
are	NULL
detected	NULL
as	NULL
yellow	NULL
signals	NULL
and	NULL
background	NULL
cells	NULL
are	NULL
seen	NULL
as	NULL
green	NULL
signals	NULL
.	NULL

The	NULL
transgenic	NULL
thymus	NULL
exhibits	NULL
increased	NULL
number	NULL
of	NULL
thymocytes	NULL
undergoing	NULL
apoptosis	NULL
.	NULL

2785	NULL
3	NULL
%	NULL
cells	NULL
were	NULL
positive	NULL
for	NULL
both	NULL
B220	NULL
and	NULL
CD43	NULL
in	NULL
the	NULL
transgenic	NULL
spleen	NULL
and	NULL
bone	NULL
marrow	NULL
(	NULL
Fig	NULL
6A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

More	NULL
remarkable	NULL
is	NULL
the	NULL
reduction	NULL
in	NULL
B220+*	NULL
CD43~	NULL
late	NULL
progenitor	NULL
population	NULL
.	NULL

In	NULL
the	NULL
transgenic	NULL
spleen	NULL
and	NULL
bone	NULL
marrow	NULL
,	NULL
this	NULL
population	NULL
was	NULL
reduced	NULL
to	NULL
5	NULL
%	NULL
to	NULL
8	NULL
%	NULL
,	NULL
as	NULL
compared	NULL
with	NULL
30	NULL
%	NULL
to	NULL
40	NULL
%	NULL
in	NULL
the	NULL
nontransgenic	NULL
spleen	NULL
and	NULL
bone	NULL
marrow	NULL
(	NULL
Fig	NULL
6A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
no	NULL
B	NULL
cells	NULL
expressing	NULL
high	NULL
levels	NULL
of	NULL
B220	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
transgenic	NULL
spleen	NULL
or	NULL
bone	NULL
marrow	NULL
(	NULL
Fig	NULL
6A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
showed	NULL
that	NULL
both	NULL
early	NULL
and	NULL
late	NULL
B-cell	NULL
progenitors	NULL
were	NULL
severely	NULL
reduced	NULL
in	NULL
the	NULL
transgenic	NULL
mice	NULL
.	NULL

We	NULL
then	NULL
investigated	NULL
whether	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
having	NULL
a	NULL
potential	NULL
to	NULL
differentiate	NULL
into	NULL
B220+*	NULL
cells	NULL
might	NULL
exist	NULL
in	NULL
the	NULL
transgenic	NULL
bone	NULL
marrow	NULL
.	NULL

The	NULL
bone	NULL
marrow	NULL
cells	NULL
from	NULL
transgenic	NULL
mice	NULL
and	NULL
nontransgenic	NULL
littermates	NULL
were	NULL
cultured	NULL
with	NULL
interleukin-7	NULL
(	NULL
IL-7	NULL
)	NULL
and	NULL
stem	NULL
cell	NULL
factor	NULL
(	NULL
SCF	NULL
)	NULL
,	NULL
which	NULL
can	NULL
recapitulate	NULL
B-cell	NULL
differentiation	NULL
in	NULL
vitro	NULL
.	NULL

'*	NULL
Interestingly	NULL
,	NULL
although	NULL
the	NULL
colony	NULL
numbers	NULL
varied	NULL
among	NULL
experiments	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
transgenic	NULL
bone	NULL
marrow	NULL
could	NULL
develop	NULL
B-cell	NULL
(	NULL
D	NULL
)	NULL
spleen	NULL
Fig	NULL
8	NULL
.	NULL

Pathological	NULL
analysis	NULL
of	NULL
acute	NULL
leukemia	NULL
developed	NULL
in	NULL
E2A-HLF	NULL
transgenic	NULL
mice	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Macroscopic	NULL
appearance	NULL
of	NULL
a	NULL
leukemic	NULL
mouse	NULL
.	NULL

The	NULL
enlarged	NULL
thymus	NULL
and	NULL
spleen	NULL
are	NULL
indicated	NULL
by	NULL
black	NULL
and	NULL
white	NULL
triangles	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
subcutaneous	NULL
lymph	NULL
node	NULL
swellings	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

(	NULL
B	NULL
)	NULL
WG-stained	NULL
peripheral	NULL
blood	NULL
smear	NULL
of	NULL
a	NULL
leukemic	NULL
mouse	NULL
.	NULL

Massive	NULL
proliferation	NULL
of	NULL
lymphoblasts	NULL
is	NULL
ap-parent	NULL
.	NULL

(	NULL
C	NULL
through	NULL
F	NULL
)	NULL
HE-stained	NULL
thymus	NULL
(	NULL
C	NULL
)	NULL
,	NULL
spleen	NULL
(	NULL
D	NULL
)	NULL
,	NULL
liver	NULL
(	NULL
E	NULL
)	NULL
,	NULL
and	NULL
kidney	NULL
(	NULL
F	NULL
)	NULL
of	NULL
a	NULL
leukemic	NULL
mouse	NULL
.	NULL

The	NULL
fundamental	NULL
structures	NULL
of	NULL
the	NULL
thymus	NULL
and	NULL
the	NULL
spleen	NULL
are	NULL
destructed	NULL
due	NULL
to	NULL
massive	NULL
proliferation	NULL
of	NULL
leukemic	NULL
cells	NULL
(	NULL
C	NULL
and	NULL
D	NULL
,	NULL
respectively	NULL
)	NULL
and	NULL
infiltration	NULL
of	NULL
leukemic	NULL
cells	NULL
is	NULL
detected	NULL
around	NULL
the	NULL
blood	NULL
vessels	NULL
in	NULL
the	NULL
liver	NULL
and	NULL
the	NULL
kidney	NULL
(	NULL
E	NULL
and	NULL
F	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2786	NULL
Table	NULL
1	NULL
.	NULL

In	NULL
Vitro	NULL
B-Cell	NULL
Colony	NULL
Formation	NULL
by	NULL
IL-7	NULL
+	NULL
SCF	NULL
+rCs	NULL
-rcs	NULL
C-1	NULL
10.5	NULL
+	NULL
3.3	NULL
10.5	NULL
+	NULL
4.4	NULL
C2	NULL
3.8	NULL
+	NULL
1.0	NULL
3.5	NULL
+	NULL
1.7	NULL
Tg-1	NULL
25.5	NULL
+	NULL
5.5	NULL
16.8	NULL
+	NULL
3.0	NULL
Tg-2	NULL
7.0	NULL
+	NULL
1.4	NULL
5.5	NULL
+	NULL
0.6	NULL
Colonies	NULL
were	NULL
generated	NULL
with	NULL
IL-7	NULL
+	NULL
SCF	NULL
with	NULL
or	NULL
without	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
.	NULL

Abbreviations	NULL
:	NULL
C	NULL
,	NULL
control	NULL
;	NULL
Tg	NULL
,	NULL
transgenic	NULL
.	NULL

colonies	NULL
as	NULL
well	NULL
as	NULL
the	NULL
nontransgenic	NULL
bone	NULL
marrow	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
the	NULL
colonies	NULL
generated	NULL
with	NULL
IL-7	NULL
and	NULL
SCF	NULL
were	NULL
committed	NULL
to	NULL
the	NULL
B-cell	NULL
lineage	NULL
,	NULL
cells	NULL
from	NULL
the	NULL
colonies	NULL
were	NULL
subjected	NULL
to	NULL
flow	NULL
cytometric	NULL
analysis	NULL
with	NULL
anti-B220	NULL
and	NULL
anti-CD43	NULL
antibodies	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
7A	NULL
,	NULL
both	NULL
colonies	NULL
were	NULL
positive	NULL
for	NULL
B220	NULL
and	NULL
showed	NULL
the	NULL
same	NULL
broad	NULL
pattern	NULL
for	NULL
CD43	NULL
,	NULL
demonstrating	NULL
that	NULL
they	NULL
both	NULL
consisted	NULL
of	NULL
early	NULL
and	NULL
late	NULL
B-cell	NULL
progenitors	NULL
.	NULL

To	NULL
further	NULL
confirm	NULL
that	NULL
the	NULL
B-cell	NULL
colonies	NULL
devel-	NULL
A	NULL
B	NULL
cell	NULL
colony	NULL
C	NULL
HONDA	NULL
ET	NULL
AL	NULL
oped	NULL
from	NULL
transgenic	NULL
bone	NULL
marrow	NULL
expressed	NULL
E2A-HLF	NULL
transgene	NULL
product	NULL
,	NULL
mRNA	NULL
extracted	NULL
from	NULL
the	NULL
colonies	NULL
were	NULL
subjected	NULL
to	NULL
RT-PCR	NULL
analysis	NULL
.	NULL

By	NULL
use	NULL
of	NULL
the	NULL
primers	NULL
encompassing	NULL
the	NULL
splicing	NULL
signal	NULL
(	NULL
P1-P4	NULL
,	NULL
see	NULL
Fig	NULL
1	NULL
)	NULL
,	NULL
the	NULL
mRNA-derived	NULL
PCR	NULL
product	NULL
(	NULL
160	NULL
bp	NULL
)	NULL
can	NULL
be	NULL
distinguished	NULL
from	NULL
any	NULL
contaminating	NULL
genome-derived	NULL
PCR	NULL
product	NULL
(	NULL
230	NULL
bp	NULL
)	NULL
,	NULL
because	NULL
70	NULL
bp	NULL
should	NULL
be	NULL
removed	NULL
by	NULL
the	NULL
splicing	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
7B	NULL
,	NULL
we	NULL
detected	NULL
the	NULL
160-bp	NULL
band	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
230-bp	NULL
band	NULL
in	NULL
the	NULL
PCR	NULL
products	NULL
generated	NULL
from	NULL
the	NULL
transgenic	NULL
colonies	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
B-cell	NULL
colonies	NULL
developed	NULL
from	NULL
transgenic	NULL
bone	NULL
marrow	NULL
expressed	NULL
transgene-derived	NULL
mRNA	NULL
.	NULL

The	NULL
overall	NULL
results	NULL
indicated	NULL
that	NULL
although	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
having	NULL
a	NULL
potential	NULL
to	NULL
differentiate	NULL
into	NULL
the	NULL
B-cell	NULL
progenitors	NULL
did	NULL
exist	NULL
in	NULL
the	NULL
transgenic	NULL
bone	NULL
marrow	NULL
,	NULL
their	NULL
commitment	NULL
to	NULL
the	NULL
B-cell	NULL
lineage	NULL
was	NULL
blocked	NULL
at	NULL
a	NULL
very	NULL
early	NULL
developmental	NULL
stage	NULL
.	NULL

Acute	NULL
lymphoblastic	NULL
leukemia	NULL
in	NULL
E2A-HLF	NULL
transgenic	NULL
mice	NULL
.	NULL

We	NULL
found	NULL
that	NULL
several	NULL
transgenic	NULL
mice	NULL
developed	NULL
acute	NULL
leukemia	NULL
.	NULL

Among	NULL
26	NULL
transgenic	NULL
mice	NULL
that	NULL
survived	NULL
more	NULL
than	NULL
4	NULL
hos	NULL
%	NULL
a	NULL
;	NULL
E	NULL
Maj	NULL
mn-C	NULL
&	NULL
it	NULL
*	NULL
<	NULL
N	NULL
N	NULL
a	NULL
|	NULL
+	NULL
b	NULL
O	NULL
|	NULL
-	NULL
]	NULL
=	NULL
.	NULL

an	NULL
an	NULL
70Â°	NULL
10+	NULL
710Â°	NULL
B220	NULL
B	NULL
E2A-HLF	NULL
C	NULL
Tg	NULL
200	NULL
bp-150	NULL
bp	NULL
K-ras	NULL
<	NULL
-	NULL
mRNA	NULL
<	NULL
4-	NULL
mRNA	NULL
10Â°	NULL
10	NULL
Â«	NULL
-	NULL
genome	NULL
Fig	NULL
7	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
the	NULL
B-cell	NULL
colonies	NULL
generated	NULL
from	NULL
bone	NULL
marrow	NULL
of	NULL
a	NULL
transgenic	NULL
mouse	NULL
(	NULL
Tg	NULL
)	NULL
and	NULL
a	NULL
nontransgenic	NULL
control	NULL
(	NULL
C	NULL
)	NULL
with	NULL
anti-B220	NULL
and	NULL
anti-CD43	NULL
antibodies	NULL
(	NULL
4	NULL
weeks	NULL
of	NULL
age	NULL
)	NULL
.	NULL

Colonies	NULL
established	NULL
from	NULL
transgenic	NULL
mice	NULL
and	NULL
nontransgenic	NULL
controls	NULL
are	NULL
similarly	NULL
positive	NULL
for	NULL
B220	NULL
and	NULL
show	NULL
the	NULL
same	NULL
broad	NULL
pattern	NULL
for	NULL
CD43	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Expression	NULL
of	NULL
transgene-derived	NULL
mRNA	NULL
in	NULL
the	NULL
transgenic	NULL
B-cell	NULL
colonies	NULL
.	NULL

The	NULL
RT-PCR	NULL
products	NULL
of	NULL
the	NULL
transgenic	NULL
colonies	NULL
(	NULL
Tg	NULL
)	NULL
and	NULL
nontransgenic	NULL
colonies	NULL
(	NULL
C	NULL
)	NULL
were	NULL
electrophoresed	NULL
in	NULL
an	NULL
agarose	NULL
gel	NULL
,	NULL
stained	NULL
with	NULL
ethidium	NULL
bromide	NULL
,	NULL
and	NULL
photographed	NULL
.	NULL

In	NULL
the	NULL
top	NULL
panel	NULL
(	NULL
E2A-HLF	NULL
)	NULL
,	NULL
products	NULL
of	NULL
genomic	NULL
and	NULL
mRNA	NULL
amplification	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
and	NULL
the	NULL
position	NULL
of	NULL
the	NULL
DNA	NULL
size	NULL
markers	NULL
are	NULL
show	NULL
n	NULL
on	NULL
the	NULL
left	NULL
.	NULL

In	NULL
the	NULL
bottom	NULL
panel	NULL
(	NULL
K-ras	NULL
)	NULL
,	NULL
K-ras	NULL
RT-PCR	NULL
products	NULL
are	NULL
show	NULL
n	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

E2A-HLF	NULL
TRANSGENIC	NULL
MICE	NULL
2787	NULL
Table	NULL
2	NULL
.	NULL

Characteristics	NULL
of	NULL
E2A-HLF	NULL
Leukemic	NULL
Mice	NULL
.	NULL

.	NULL

.	NULL

Hematological	NULL
Examination	NULL
Mouse	NULL
No	NULL
.	NULL

Age	NULL
at	NULL
Diagnosis	NULL
Macroscopic	NULL
Surface	NULL
Marker	NULL
DNA	NULL
Status	NULL
(	NULL
sex	NULL
)	NULL
{	NULL
mo	NULL
)	NULL
Tumor	NULL
Sites	NULL
WBC	NULL
(	NULL
x109uL	NULL
)	NULL
Hb	NULL
(	NULL
g/dL	NULL
)	NULL
Pit	NULL
Analysis	NULL
(	NULL
ICR	NULL
)	NULL
Thy1.2	NULL
(	NULL
+	NULL
)	NULL
1-17-9	NULL
5.5	NULL
Thy	NULL
,	NULL
Spl	NULL
,	NULL
LN	NULL
43.8	NULL
4.5	NULL
6.2	NULL
CD4	NULL
(	NULL
-	NULL
)	NULL
CD8	NULL
(	NULL
+	NULL
)	NULL
G/R	NULL
(	NULL
M	NULL
)	NULL
(	NULL
>	NULL
90	NULL
%	NULL
lymphoblasts	NULL
)	NULL
B220	NULL
(	NULL
-	NULL
)	NULL
Thy1.2	NULL
(	NULL
+	NULL
)	NULL
2-17-2	NULL
6.0	NULL
Thy	NULL
,	NULL
Spl	NULL
,	NULL
LN	NULL
20.5	NULL
8.0	NULL
10.5	NULL
CD4	NULL
(	NULL
+	NULL
)	NULL
CD8	NULL
(	NULL
+	NULL
)	NULL
G/R	NULL
(	NULL
F	NULL
)	NULL
(	NULL
>	NULL
90	NULL
%	NULL
lymphoblasts	NULL
)	NULL
B220	NULL
(	NULL
-	NULL
)	NULL
Thy1.2	NULL
(	NULL
+	NULL
)	NULL
2-17-8-2	NULL
4.2	NULL
Thy	NULL
,	NULL
Spl	NULL
,	NULL
LN	NULL
19.8	NULL
7.7	NULL
22.2	NULL
CD4	NULL
(	NULL
+	NULL
)	NULL
CD8	NULL
(	NULL
-	NULL
)	NULL
G/R	NULL
(	NULL
F	NULL
)	NULL
(	NULL
>	NULL
90	NULL
%	NULL
lymphoblasts	NULL
)	NULL
B220	NULL
(	NULL
-	NULL
)	NULL
Thy1.2	NULL
(	NULL
+	NULL
)	NULL
2-17-8-4	NULL
5.2	NULL
Thy	NULL
,	NULL
Spl	NULL
,	NULL
LN	NULL
15.6	NULL
8.5	NULL
23.3	NULL
CD4	NULL
(	NULL
+	NULL
)	NULL
CD8	NULL
(	NULL
-	NULL
)	NULL
G/R	NULL
(	NULL
F	NULL
)	NULL
(	NULL
>	NULL
90	NULL
%	NULL
lymphoblasts	NULL
)	NULL
B220	NULL
(	NULL
-	NULL
)	NULL
Thy1.2	NULL
(	NULL
+	NULL
)	NULL
2-17-10-8	NULL
3.1	NULL
Thy	NULL
,	NULL
Spl	NULL
,	NULL
LN	NULL
52.3	NULL
8.1	NULL
30.1	NULL
CD4	NULL
(	NULL
+	NULL
)	NULL
CD8	NULL
(	NULL
-	NULL
)	NULL
G/R	NULL
(	NULL
M	NULL
)	NULL
(	NULL
>	NULL
90	NULL
%	NULL
lymphoblasts	NULL
)	NULL
B220	NULL
(	NULL
-	NULL
)	NULL
Abbreviations	NULL
:	NULL
M	NULL
,	NULL
male	NULL
;	NULL
F	NULL
,	NULL
female	NULL
;	NULL
Thy	NULL
,	NULL
thymus	NULL
;	NULL
Spl	NULL
,	NULL
spleen	NULL
;	NULL
LN	NULL
,	NULL
lymph	NULL
node	NULL
;	NULL
WBC	NULL
,	NULL
white	NULL
blood	NULL
cell	NULL
count	NULL
;	NULL
G	NULL
,	NULL
germline	NULL
;	NULL
R	NULL
,	NULL
rearranged	NULL
.	NULL

months	NULL
,	NULL
5	NULL
have	NULL
developed	NULL
acute	NULL
leukemia	NULL
.	NULL

All	NULL
the	NULL
leukemic	NULL
mice	NULL
exhibited	NULL
massive	NULL
thymic	NULL
enlargement	NULL
,	NULL
splenomegaly	NULL
,	NULL
and	NULL
lymph	NULL
node	NULL
swelling	NULL
(	NULL
Fig	NULL
8A	NULL
[	NULL
see	NULL
page	NULL
2785	NULL
]	NULL
)	NULL
.	NULL

The	NULL
peripheral	NULL
blood	NULL
smears	NULL
of	NULL
these	NULL
mice	NULL
showed	NULL
massive	NULL
proliferation	NULL
of	NULL
blast	NULL
cells	NULL
with	NULL
no	NULL
granules	NULL
,	NULL
having	NULL
the	NULL
appearance	NULL
of	NULL
lymphoblasts	NULL
(	NULL
Fig	NULL
8B	NULL
)	NULL
.	NULL

Pathological	NULL
analyses	NULL
showed	NULL
infiltration	NULL
of	NULL
leukemic	NULL
cells	NULL
into	NULL
almost	NULL
all	NULL
tissues	NULL
examined	NULL
,	NULL
especially	NULL
in	NULL
the	NULL
thymus	NULL
,	NULL
spleen	NULL
,	NULL
liver	NULL
,	NULL
and	NULL
kidney	NULL
(	NULL
Fig	NULL
8C	NULL
through	NULL
F	NULL
)	NULL
.	NULL

The	NULL
characteristics	NULL
of	NULL
the	NULL
leukemic	NULL
mice	NULL
are	NULL
summarized	NULL
in	NULL
Table	NULL
2	NULL
.	NULL

Surface	NULL
marker	NULL
analysis	NULL
of	NULL
the	NULL
leukemic	NULL
cells	NULL
showed	NULL
that	NULL
all	NULL
the	NULL
leukemic	NULL
cells	NULL
were	NULL
positive	NULL
for	NULL
Thy1.2	NULL
but	NULL
negative	NULL
for	NULL
B220	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
leukemias	NULL
were	NULL
of	NULL
a	NULL
T-cell	NULL
phenotype	NULL
.	NULL

Staining	NULL
of	NULL
the	NULL
leukemic	NULL
cells	NULL
with	NULL
anti-CD4	NULL
and	NULL
anti-CD8	NULL
antibodies	NULL
showed	NULL
that	NULL
one	NULL
tumor	NULL
was	NULL
double	NULL
positive	NULL
(	NULL
CD4*	NULL
CD8+*	NULL
)	NULL
but	NULL
three	NULL
cases	NULL
were	NULL
single	NULL
positive	NULL
for	NULL
CD4	NULL
(	NULL
CD4+	NULL
CD8~	NULL
)	NULL
and	NULL
the	NULL
other	NULL
one	NULL
case	NULL
was	NULL
single	NULL
positive	NULL
for	NULL
CD8	NULL
(	NULL
CD4~	NULL
CD8+*	NULL
)	NULL
.	NULL

The	NULL
clonality	NULL
of	NULL
the	NULL
leukemic	NULL
cells	NULL
was	NULL
shown	NULL
by	NULL
Southern	NULL
blot	NULL
analysis	NULL
using	NULL
T-cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
-y	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
leukemias	NULL
developed	NULL
in	NULL
the	NULL
transgenic	NULL
mice	NULL
were	NULL
clonal	NULL
T-cell	NULL
tumors	NULL
.	NULL

DISCUSSION	NULL
Generation	NULL
of	NULL
transgenic	NULL
mice	NULL
has	NULL
successfully	NULL
been	NULL
used	NULL
for	NULL
investigating	NULL
gene	NULL
functions	NULL
in	NULL
Transgenic	NULL
mice	NULL
have	NULL
provided	NULL
significant	NULL
insights	NULL
into	NULL
the	NULL
biological	NULL
properties	NULL
of	NULL
the	NULL
chimeric	NULL
gene	NULL
product	NULL
,	NULL
especially	NULL
for	NULL
genes	NULL
that	NULL
are	NULL
activated	NULL
by	NULL
chromosomal	NULL
translocations	NULL
,	NULL
such	NULL
as	NULL
Ber/Abl	NULL
and	NULL
PML/	NULL
RARa	NULL
.	NULL
'	NULL

>	NULL
Thus	NULL
,	NULL
we	NULL
applied	NULL
this	NULL
technique	NULL
to	NULL
investigate	NULL
the	NULL
biological	NULL
function	NULL
of	NULL
EZ2A-HLF	NULL
The	NULL
use	NULL
of	NULL
Ig	NULL
enhancer/	NULL
promoter	NULL
allowed	NULL
us	NULL
to	NULL
express	NULL
the	NULL
Â£2A-HLF	NULL
transgene	NULL
product	NULL
in	NULL
both	NULL
T	NULL
and	NULL
B	NULL
lymphocytes	NULL
(	NULL
Fig	NULL
1B	NULL
and	NULL
C	NULL
)	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
previous	NULL
reports	NULL
.	NULL
``	NULL

''	NULL
Failure	NULL
in	NULL
detecting	NULL
the	NULL
Â£2A-HLF	NULL
protein	NULL
in	NULL
the	NULL
transgenic	NULL
spleen	NULL
by	NULL
immunoprecipitation/Western	NULL
blot	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
was	NULL
probably	NULL
due	NULL
to	NULL
the	NULL
reduction	NULL
in	NULL
B	NULL
lymphocytes	NULL
(	NULL
Figs	NULL
4B	NULL
and	NULL
6A	NULL
)	NULL
.	NULL

Histological	NULL
analysis	NULL
showed	NULL
remarkable	NULL
changes	NULL
in	NULL
the	NULL
thymus	NULL
and	NULL
in	NULL
the	NULL
spleen	NULL
(	NULL
Fig	NULL
4A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

The	NULL
overall	NULL
decrease	NULL
in	NULL
thymocytes	NULL
and	NULL
marked	NULL
reduction	NULL
in	NULL
splenic	NULL
lymphocytes	NULL
indicated	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
E2A-HLF	NULL
impaired	NULL
normal	NULL
lymphocyte	NULL
development	NULL
in	NULL
both	NULL
T	NULL
and	NULL
B	NULL
lineages	NULL
.	NULL

These	NULL
results	NULL
enabled	NULL
us	NULL
to	NULL
explain	NULL
the	NULL
cause	NULL
of	NULL
the	NULL
high	NULL
mortality	NULL
rate	NULL
observed	NULL
in	NULL
the	NULL
transgenic	NULL
mice	NULL
.	NULL

Reduction	NULL
in	NULL
the	NULL
lymphocyte	NULL
number	NULL
would	NULL
render	NULL
the	NULL
transgenic	NULL
mice	NULL
immunodeficient	NULL
and	NULL
highly	NULL
susceptible	NULL
to	NULL
fatal	NULL
infections	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
transgenic	NULL
mice	NULL
kept	NULL
in	NULL
a	NULL
clean	NULL
isolator	NULL
survived	NULL
much	NULL
longer	NULL
than	NULL
those	NULL
maintained	NULL
under	NULL
a	NULL
conventional	NULL
condition	NULL
supports	NULL
this	NULL
idea	NULL
.	NULL

The	NULL
reason	NULL
why	NULL
the	NULL
phenotypic	NULL
changes	NULL
(	NULL
emaciation	NULL
and	NULL
death	NULL
)	NULL
were	NULL
not	NULL
observed	NULL
before	NULL
weaning	NULL
could	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
notion	NULL
that	NULL
the	NULL
maternal	NULL
Ig	NULL
would	NULL
be	NULL
transmitted	NULL
through	NULL
the	NULL
milk	NULL
and	NULL
rescue	NULL
the	NULL
immunodeficiency	NULL
of	NULL
the	NULL
transgenic	NULL
mice	NULL
,	NULL
as	NULL
suggested	NULL
in	NULL
a	NULL
previous	NULL
report	NULL
.	NULL
``	NULL

''	NULL
The	NULL
TUNEL	NULL
staining	NULL
showed	NULL
that	NULL
the	NULL
decrease	NULL
in	NULL
thymocyte	NULL
number	NULL
was	NULL
caused	NULL
by	NULL
increased	NULL
apoptosis	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
flow	NULL
cytometric	NULL
analysis	NULL
demonstrated	NULL
that	NULL
the	NULL
marked	NULL
reduction	NULL
in	NULL
splenic	NULL
lymphocytes	NULL
was	NULL
caused	NULL
by	NULL
the	NULL
maturation	NULL
block	NULL
of	NULL
B	NULL
lymphocytes	NULL
at	NULL
a	NULL
very	NULL
early	NULL
developmental	NULL
stage	NULL
(	NULL
Fig	NULL
6A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
Â£2A-HLF	NULL
in	NULL
lymphoid	NULL
cells	NULL
induced	NULL
T-cell	NULL
apoptosis	NULL
and	NULL
B-cell	NULL
maturation	NULL
arrest	NULL
in	NULL
vivo	NULL
.	NULL

Although	NULL
the	NULL
precise	NULL
mechanism	NULL
is	NULL
not	NULL
clear	NULL
,	NULL
it	NULL
could	NULL
be	NULL
supposed	NULL
that	NULL
Â£E2A-HLF	NULL
induced	NULL
expression	NULL
of	NULL
genes	NULL
regulating	NULL
cell	NULL
survival	NULL
and	NULL
cell	NULL
death	NULL
and	NULL
led	NULL
to	NULL
impairment	NULL
of	NULL
normal	NULL
lymphoid	NULL
development	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
expression	NULL
levels	NULL
of	NULL
several	NULL
candidate	NULL
genes	NULL
,	NULL
including	NULL
bel-2	NULL
,	NULL
``	NULL
``	NULL
bel-x	NULL
,	NULL
``	NULL
``	NULL
and	NULL
Fas	NULL
,	NULL
``	NULL
in	NULL
the	NULL
transgenic	NULL
and	NULL
nontransgenic	NULL
thymuses	NULL
.	NULL

Because	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
any	NULL
differences	NULL
in	NULL
their	NULL
expression	NULL
levels	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
the	NULL
abnormal	NULL
lymphocyte	NULL
development	NULL
would	NULL
be	NULL
caused	NULL
by	NULL
other	NULL
mechanism	NULL
(	NULL
s	NULL
)	NULL
than	NULL
we	NULL
examined	NULL
.	NULL

Interestingly	NULL
,	NULL
although	NULL
B-cell	NULL
maturation	NULL
was	NULL
blocked	NULL
at	NULL
a	NULL
very	NULL
early	NULL
stage	NULL
in	NULL
vivo	NULL
,	NULL
transgenic	NULL
bone	NULL
marrow	NULL
cells	NULL
restored	NULL
the	NULL
ability	NULL
of	NULL
developing	NULL
B-cell	NULL
progenitors	NULL
in	NULL
vitro	NULL
(	NULL
Fig	NULL
7	NULL
and	NULL
Table	NULL
1	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
some	NULL
in	NULL
vivo	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
might	NULL
contribute	NULL
to	NULL
the	NULL
abnormal	NULL
lymphoid	NULL
development	NULL
in	NULL
cooperation	NULL
with	NULL
Â£2A-HLF	NULL
.	NULL

Increased	NULL
T-cell	NULL
apoptosis	NULL
observed	NULL
in	NULL
E2A-HLF	NULL
transgenic	NULL
mice	NULL
seems	NULL
to	NULL
be	NULL
inconsistent	NULL
with	NULL
the	NULL
results	NULL
of	NULL
experiments	NULL
using	NULL
in	NULL
vitro	NULL
cell	NULL
systems	NULL
,	NULL
which	NULL
demonstrated	NULL
an	NULL
antiapoptotic	NULL
function	NULL
of	NULL
E2A-HLF	NULL
.	NULL

``	NULL
``	NULL
``	NULL
Â°	NULL
One	NULL
possible	NULL
explanation	NULL
is	NULL
the	NULL
difference	NULL
in	NULL
the	NULL
cell	NULL
lineages	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
UOC-B1	NULL
cells	NULL
,	NULL
which	NULL
was	NULL
established	NULL
from	NULL
human	NULL
pro-B	NULL
leukemia	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2788	NULL
expressing	NULL
E2A-HLF	NULL
,	NULL
underwent	NULL
apoptosis	NULL
by	NULL
the	NULL
induction	NULL
of	NULL
a	NULL
dominant-negative	NULL
form	NULL
of	NULL
E2A-HLF	NULL
.	NULL
``	NULL

In	NULL
addition	NULL
,	NULL
two	NULL
murine	NULL
IL-3-dependent	NULL
pro-B	NULL
cell	NULL
lines	NULL
,	NULL
Ba/F3	NULL
and	NULL
FL5.12	NULL
,	NULL
became	NULL
resistant	NULL
to	NULL
apoptosis	NULL
caused	NULL
by	NULL
IL-3	NULL
depletion	NULL
when	NULL
Â£E2A-HLF	NULL
was	NULL
expressed	NULL
in	NULL
these	NULL
cells	NULL
.	NULL
``	NULL

''	NULL
``	NULL
However	NULL
,	NULL
E2A-HLF	NULL
failed	NULL
to	NULL
reverse	NULL
apoptosis	NULL
in	NULL
cytokine-derived	NULL
32D	NULL
cells	NULL
,	NULL
a	NULL
murine	NULL
IL-3-dependent	NULL
myeloid	NULL
cell	NULL
line	NULL
(	NULL
our	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
anti-apoptotic	NULL
function	NULL
of	NULL
Â£2A-HLF	NULL
might	NULL
be	NULL
confined	NULL
to	NULL
B-lineage	NULL
lymphocytes	NULL
.	NULL

Maturation	NULL
arrest	NULL
of	NULL
B	NULL
lymphocytes	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
may	NULL
agree	NULL
with	NULL
our	NULL
recent	NULL
result	NULL
obtained	NULL
using	NULL
an	NULL
in	NULL
vitro	NULL
experimental	NULL
system	NULL
that	NULL
CD20	NULL
,	NULL
a	NULL
well-known	NULL
cell-surface	NULL
marker	NULL
for	NULL
B-cell	NULL
maturation	NULL
,	NULL
is	NULL
induced	NULL
by	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
dominant-negative	NULL
form	NULL
of	NULL
E2A-HLF	NULL
in	NULL
UOC-B1	NULL
cells	NULL
.	NULL
``	NULL

It	NULL
is	NULL
to	NULL
be	NULL
noted	NULL
that	NULL
several	NULL
transgenic	NULL
mice	NULL
developed	NULL
acute	NULL
leukemia	NULL
.	NULL

The	NULL
leukemic	NULL
mice	NULL
exhibited	NULL
thymic	NULL
enlargement	NULL
,	NULL
splenomegaly	NULL
,	NULL
and	NULL
lymph	NULL
node	NULL
swelling	NULL
(	NULL
Fig	NULL
8A	NULL
)	NULL
.	NULL

The	NULL
leukemic	NULL
cells	NULL
,	NULL
having	NULL
the	NULL
appearance	NULL
of	NULL
lymphoblasts	NULL
(	NULL
Fig	NULL
8B	NULL
)	NULL
,	NULL
were	NULL
highly	NULL
malignant	NULL
,	NULL
showing	NULL
massive	NULL
infiltration	NULL
into	NULL
almost	NULL
all	NULL
the	NULL
tissues	NULL
examined	NULL
(	NULL
Fig	NULL
8C	NULL
through	NULL
F	NULL
)	NULL
.	NULL

The	NULL
leukemic	NULL
cells	NULL
were	NULL
positive	NULL
for	NULL
Thy1.2	NULL
and	NULL
carried	NULL
rearrangements	NULL
in	NULL
TCR	NULL
loci	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
they	NULL
were	NULL
clonal	NULL
T-cell	NULL
tumors	NULL
.	NULL

However	NULL
,	NULL
the	NULL
expression	NULL
patterns	NULL
of	NULL
CD4	NULL
and	NULL
CD8	NULL
in	NULL
each	NULL
leukemia	NULL
were	NULL
heterogeneous	NULL
;	NULL
one	NULL
tumor	NULL
was	NULL
double-positive	NULL
for	NULL
CD4	NULL
and	NULL
CD8	NULL
,	NULL
three	NULL
tumors	NULL
were	NULL
single-positive	NULL
for	NULL
CD4	NULL
,	NULL
and	NULL
the	NULL
other	NULL
one	NULL
case	NULL
was	NULL
single-positive	NULL
for	NULL
CD8	NULL
.	NULL

Thus	NULL
,	NULL
E2A-HLF	NULL
rendered	NULL
an	NULL
oncogenic	NULL
activity	NULL
to	NULL
T	NULL
cells	NULL
that	NULL
are	NULL
in	NULL
transition	NULL
from	NULL
double-positive	NULL
to	NULL
single-positive	NULL
stage	NULL
of	NULL
development	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
E2A-HLF	NULL
possesses	NULL
an	NULL
oncogenic	NULL
potential	NULL
in	NULL
addition	NULL
to	NULL
inducing	NULL
T-cell	NULL
apoptosis	NULL
and	NULL
B-cell	NULL
maturation	NULL
block	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
5	NULL
of	NULL
26	NULL
mice	NULL
that	NULL
survived	NULL
more	NULL
than	NULL
4	NULL
months	NULL
developed	NULL
ALL	NULL
may	NULL
suggest	NULL
that	NULL
an	NULL
additional	NULL
genetic	NULL
event	NULL
might	NULL
be	NULL
required	NULL
for	NULL
disease	NULL
development	NULL
.	NULL

This	NULL
idea	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
findings	NULL
that	NULL
E2A-HLF	NULL
exhibited	NULL
an	NULL
oncogenic	NULL
ability	NULL
in	NULL
NIH	NULL
3T3	NULL
cells	NULL
'	NULL
``	NULL
and	NULL
showed	NULL
an	NULL
anti-apoptotic	NULL
activity	NULL
in	NULL
Ba/F3	NULL
cells	NULL
,	NULL
``	NULL
since	NULL
the	NULL
transfected	NULL
cells	NULL
are	NULL
immortalized	NULL
and	NULL
would	NULL
carry	NULL
a	NULL
genetic	NULL
abnormality	NULL
(	NULL
ies	NULL
)	NULL
for	NULL
immortalization	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
E2A-HLF	NULL
contributes	NULL
to	NULL
leukemogenesis	NULL
in	NULL
cooperation	NULL
with	NULL
another	NULL
or	NULL
more	NULL
genetic	NULL
event	NULL
(	NULL
s	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
phenotypic	NULL
aspects	NULL
observed	NULL
in	NULL
the	NULL
Â£2A-HLF	NULL
transgenic	NULL
mice	NULL
(	NULL
T-cell	NULL
apoptosis	NULL
,	NULL
B-cell	NULL
maturation	NULL
block	NULL
,	NULL
and	NULL
T-cell	NULL
leukemia	NULL
)	NULL
closely	NULL
resemble	NULL
those	NULL
reported	NULL
in	NULL
the	NULL
transgenic	NULL
mice	NULL
expressing	NULL
another	NULL
EZ2A-involving	NULL
chimeric	NULL
protein	NULL
,	NULL
EZ2A-PBX1	NULL
,	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
same	NULL
Ig	NULL
promoter/	NULL
enhancer	NULL
.	NULL
``	NULL

If	NULL
aberrant	NULL
gene	NULL
transcription	NULL
induced	NULL
by	NULL
E24-HLF	NULL
or	NULL
E2A-PBXI	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
phenotypes	NULL
,	NULL
the	NULL
phenotypic	NULL
coincidence	NULL
between	NULL
both	NULL
types	NULL
of	NULL
transgenic	NULL
mice	NULL
seems	NULL
to	NULL
be	NULL
anomalous	NULL
,	NULL
because	NULL
the	NULL
DNA-binding	NULL
activities	NULL
of	NULL
E2A-HLF	NULL
and	NULL
E2ZA-PBX1	NULL
are	NULL
dependent	NULL
on	NULL
HLF-	NULL
and	NULL
PBX1l-derived	NULL
regions	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
their	NULL
experimentally	NULL
defined	NULL
binding	NULL
motifs	NULL
are	NULL
completely	NULL
different	NULL
(	NULL
5'-GTTACGTAAT-3	NULL
'	NULL
for	NULL
HLF	NULL
and	NULL
5'-ATCAATCAA-3	NULL
'	NULL
for	NULL
PBX1	NULL
)	NULL
.	NULL
``	NULL

''	NULL
One	NULL
possible	NULL
explanation	NULL
for	NULL
this	NULL
is	NULL
that	NULL
a	NULL
gene	NULL
(	NULL
s	NULL
)	NULL
that	NULL
is	NULL
a	NULL
common	NULL
target	NULL
of	NULL
both	NULL
E2A-HLF	NULL
and	NULL
E2A-PBX1	NULL
exists	NULL
,	NULL
and	NULL
its	NULL
aberrant	NULL
expression	NULL
in	NULL
lymphoid	NULL
cells	NULL
impaired	NULL
normal	NULL
lymphoid	NULL
development	NULL
and	NULL
led	NULL
to	NULL
phenotypic	NULL
abnormalities	NULL
.	NULL

Another	NULL
possibility	NULL
,	NULL
which	NULL
seems	NULL
to	NULL
be	NULL
more	NULL
likely	NULL
,	NULL
is	NULL
that	NULL
the	NULL
phenotypes	NULL
commonly	NULL
observed	NULL
in	NULL
both	NULL
transgenic	NULL
mice	NULL
were	NULL
caused	NULL
by	NULL
a	NULL
dominant-negative	NULL
HONDA	NULL
ET	NULL
AL	NULL
inhibition	NULL
of	NULL
Â£24	NULL
activity	NULL
.	NULL

This	NULL
idea	NULL
could	NULL
be	NULL
supported	NULL
by	NULL
the	NULL
finding	NULL
that	NULL
mice	NULL
lacking	NULL
E24	NULL
also	NULL
exhibited	NULL
very	NULL
similar	NULL
phenotypes	NULL
.	NULL

E2A-deficient	NULL
mice	NULL
failed	NULL
to	NULL
generate	NULL
B220*	NULL
cells	NULL
because	NULL
of	NULL
maturation	NULL
arrest	NULL
of	NULL
B	NULL
cells	NULL
at	NULL
an	NULL
early	NULL
developmental	NULL
stage	NULL
.	NULL
``	NULL

''	NULL
In	NULL
addition	NULL
,	NULL
they	NULL
contained	NULL
a	NULL
low	NULL
number	NULL
of	NULL
thymocytes	NULL
and	NULL
eventually	NULL
developed	NULL
T-cell	NULL
lymphomas	NULL
.	NULL
``	NULL

Thus	NULL
,	NULL
it	NULL
would	NULL
be	NULL
possible	NULL
to	NULL
consider	NULL
that	NULL
the	NULL
biological	NULL
properties	NULL
of	NULL
E2A-HLF	NULL
and	NULL
E2A-PBX1	NULL
are	NULL
caused	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
by	NULL
interfering	NULL
Â£24	NULL
function	NULL
.	NULL

The	NULL
results	NULL
of	NULL
functional	NULL
studies	NULL
of	NULL
E2A-HLF	NULL
and	NULL
E2A-PBXI	NULL
using	NULL
cell	NULL
lines	NULL
support	NULL
this	NULL
idea	NULL
.	NULL

The	NULL
Â£E2A-derived	NULL
regions	NULL
of	NULL
E2A-HLF	NULL
and	NULL
E2A-PBX1	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
required	NULL
for	NULL
the	NULL
transactivating	NULL
and	NULL
transforming	NULL
abilities	NULL
in	NULL
both	NULL
chimeric	NULL
proteins'*	NULL
``	NULL
``	NULL
``	NULL
``	NULL
and	NULL
also	NULL
for	NULL
the	NULL
anti-apoptotic	NULL
function	NULL
of	NULL
E2A-HLF	NULL
in	NULL
TIL-3-dependent	NULL
murine	NULL
lymphocytes	NULL
.	NULL
``	NULL

''	NULL
In	NULL
con-trast	NULL
,	NULL
the	NULL
bZIP	NULL
domain	NULL
of	NULL
HLF	NULL
and	NULL
the	NULL
homeodomain	NULL
of	NULL
which	NULL
mediate	NULL
site-specific	NULL
DNA-binding	NULL
capacities	NULL
of	NULL
Â£E2A-HLF	NULL
and	NULL
EZA-PBX1	NULL
,	NULL
respectively	NULL
,	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
unnecessary	NULL
for	NULL
the	NULL
transforming	NULL
ability	NULL
of	NULL
or	NULL
for	NULL
anti-apoptotic	NULL
function	NULL
of	NULL
E2A-HLFEÂ®	NULL
``	NULL
Tal-1	NULL
(	NULL
also	NULL
called	NULL
as	NULL
SCL	NULL
)	NULL
,	NULL
which	NULL
is	NULL
a	NULL
transcription	NULL
factor	NULL
belonging	NULL
the	NULL
bHLH	NULL
family	NULL
and	NULL
is	NULL
involved	NULL
in	NULL
human	NULL
T-ALL	NULL
,	NULL
is	NULL
shown	NULL
to	NULL
directly	NULL
bind	NULL
to	NULL
Â£244	NULL
%	NULL
'	NULL
and	NULL
is	NULL
considered	NULL
to	NULL
contribute	NULL
to	NULL
leukemogenesis	NULL
by	NULL
interfering	NULL
normal	NULL
E2A	NULL
function	NULL
through	NULL
forming	NULL
a	NULL
heterodimer	NULL
with	NULL
Â£24	NULL
.	NULL
``	NULL

However	NULL
,	NULL
it	NULL
is	NULL
not	NULL
the	NULL
case	NULL
of	NULL
E2A-HLF	NULL
and	NULL
EZA-PBX1	NULL
,	NULL
because	NULL
the	NULL
dimerization	NULL
domain	NULL
of	NULL
Â£24	NULL
is	NULL
deleted	NULL
in	NULL
both	NULL
proteins	NULL
.	NULL

*	NULL
``	NULL
Thus	NULL
,	NULL
although	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
abnormal	NULL
lymphocyte	NULL
development	NULL
observed	NULL
in	NULL
the	NULL
transgenic	NULL
mice	NULL
would	NULL
be	NULL
induced	NULL
by	NULL
a	NULL
dominant-negative	NULL
effect	NULL
on	NULL
E24	NULL
function	NULL
,	NULL
the	NULL
underlying	NULL
mechanisms	NULL
have	NULL
remained	NULL
to	NULL
be	NULL
established	NULL
.	NULL

One	NULL
possibility	NULL
to	NULL
be	NULL
investigated	NULL
is	NULL
that	NULL
E2A-HLF	NULL
and	NULL
E2A-PBX1	NULL
might	NULL
competitively	NULL
bind	NULL
to	NULL
a	NULL
specific	NULL
interaction	NULL
partner	NULL
of	NULL
the	NULL
activation	NULL
domain	NULL
of	NULL
Â£24	NULL
that	NULL
is	NULL
expressed	NULL
in	NULL
lymphoid	NULL
cells	NULL
and	NULL
is	NULL
required	NULL
for	NULL
Â£24	NULL
activity	NULL
,	NULL
through	NULL
which	NULL
they	NULL
inhibit	NULL
Â£24	NULL
function	NULL
and	NULL
induce	NULL
an	NULL
E2A-deficient	NULL
phenotype	NULL
.	NULL

There	NULL
remains	NULL
a	NULL
question	NULL
concerning	NULL
the	NULL
difference	NULL
in	NULL
the	NULL
immunophenotypes	NULL
of	NULL
the	NULL
leukemias	NULL
between	NULL
humans	NULL
and	NULL
mice	NULL
.	NULL

In	NULL
humans	NULL
,	NULL
Â£2A-PBX	NULL
]	NULL
is	NULL
detected	NULL
in	NULL
pre-B	NULL
cell	NULL
leuke-mias	NULL
``	NULL
and	NULL
EZA-HLF	NULL
is	NULL
associated	NULL
with	NULL
pro-B	NULL
type	NULL
leuke-mias	NULL
,	NULL
``	NULL
whereas	NULL
the	NULL
leukemias	NULL
developed	NULL
in	NULL
the	NULL
transgenic	NULL
mice	NULL
have	NULL
so	NULL
far	NULL
been	NULL
diagnosed	NULL
as	NULL
T-ALL	NULL
(	NULL
and	NULL
this	NULL
report	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
reason	NULL
is	NULL
not	NULL
clear	NULL
,	NULL
one	NULL
possibility	NULL
is	NULL
that	NULL
Ig	NULL
enhancer/promoter	NULL
allowed	NULL
transgene	NULL
expression	NULL
in	NULL
both	NULL
in	NULL
T	NULL
and	NULL
B	NULL
lymphocytes	NULL
,	NULL
and	NULL
T	NULL
cells	NULL
might	NULL
be	NULL
more	NULL
susceptible	NULL
to	NULL
the	NULL
oncogenic	NULL
properties	NULL
of	NULL
the	NULL
chimeric	NULL
proteins	NULL
.	NULL

The	NULL
generation	NULL
of	NULL
knock-in	NULL
mice	NULL
expressing	NULL
E2A-HLF	NULL
and	NULL
EZA-PBX1	NULL
under	NULL
the	NULL
control	NULL
of	NULL
native	NULL
E2A	NULL
promoter	NULL
might	NULL
clarify	NULL
the	NULL
problem	NULL
concerning	NULL
the	NULL
phenotypic	NULL
disparity	NULL
between	NULL
humans	NULL
and	NULL
mice	NULL
.	NULL

ACKNOWLEDGMENT	NULL
We	NULL
thank	NULL
Dr	NULL
TW	NULL
.	NULL

Mak	NULL
for	NULL
providing	NULL
the	NULL
mouse	NULL
TCR-y	NULL
probe	NULL
.	NULL

We	NULL
thank	NULL
Yoshikazu	NULL
Oh-hira	NULL
for	NULL
preparing	NULL
pathological	NULL
specimens	NULL
,	NULL
and	NULL
we	NULL
also	NULL
thank	NULL
Haruki	NULL
Kume	NULL
for	NULL
photographs	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Rabbitts	NULL
TH	NULL
:	NULL
Chromosomal	NULL
translocations	NULL
in	NULL
human	NULL
cancer	NULL
[	NULL
re-view	NULL
]	NULL
.	NULL

Nature	NULL
372:143	NULL
,	NULL
1994	NULL
2	NULL
.	NULL

Cleary	NULL
ML	NULL
:	NULL
Oncogenic	NULL
conversion	NULL
of	NULL
transcription	NULL
factors	NULL
by	NULL
chromosomal	NULL
translocations	NULL
.	NULL

Cell	NULL
66:619	NULL
,	NULL
1991	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

E2A-HLF	NULL
TRANSGENIC	NULL
MICE	NULL
3	NULL
.	NULL

Kamps	NULL
MP	NULL
,	NULL
Murre	NULL
C	NULL
,	NULL
Sun	NULL
XH	NULL
,	NULL
Baltimore	NULL
D	NULL
:	NULL
A	NULL
new	NULL
homeobox	NULL
gene	NULL
contributes	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
the	NULL
t	NULL
(	NULL
1	NULL
;	NULL
19	NULL
)	NULL
translocation	NULL
protein	NULL
in	NULL
pre-B	NULL
ALL	NULL
.	NULL

Cell	NULL
60:547	NULL
,	NULL
1990	NULL
4	NULL
.	NULL

Nourse	NULL
J	NULL
,	NULL
Mellentin	NULL
JD	NULL
,	NULL
Galili	NULL
N	NULL
,	NULL
Wilkinson	NULL
J	NULL
,	NULL
Stanbridge	NULL
E	NULL
,	NULL
Smith	NULL
SD	NULL
,	NULL
Cleary	NULL
ML	NULL
:	NULL
Chromosomal	NULL
translocation	NULL
t	NULL
(	NULL
1	NULL
;	NULL
19	NULL
)	NULL
results	NULL
in	NULL
synthesis	NULL
of	NULL
a	NULL
homeobox	NULL
fusion	NULL
mRNA	NULL
that	NULL
codes	NULL
for	NULL
a	NULL
potential	NULL
chimeric	NULL
transcription	NULL
factor	NULL
.	NULL

Cell	NULL
60:535	NULL
,	NULL
1990	NULL
5	NULL
.	NULL

Inaba	NULL
T	NULL
,	NULL
Roberts	NULL
WM	NULL
,	NULL
Shapiro	NULL
LH	NULL
,	NULL
Jolly	NULL
KW	NULL
,	NULL
Raimondi	NULL
SC	NULL
,	NULL
Smith	NULL
SD	NULL
,	NULL
Look	NULL
AT	NULL
:	NULL
Fusion	NULL
of	NULL
the	NULL
leucine	NULL
zipper	NULL
gene	NULL
HLF	NULL
to	NULL
the	NULL
EZA	NULL
gene	NULL
in	NULL
human	NULL
acute	NULL
B-lineage	NULL
leukemia	NULL
.	NULL

Science	NULL
257:531	NULL
,	NULL
1992	NULL
6	NULL
.	NULL

Hunger	NULL
SP	NULL
,	NULL
Ohyashiki	NULL
K	NULL
,	NULL
Toyama	NULL
K	NULL
,	NULL
Cleary	NULL
ML	NULL
:	NULL
HLF	NULL
,	NULL
a	NULL
novel	NULL
hepatic	NULL
bZIP	NULL
protein	NULL
,	NULL
shows	NULL
altered	NULL
DNA-binding	NULL
properties	NULL
following	NULL
fusion	NULL
to	NULL
EZA	NULL
in	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
.	NULL

Genes	NULL
Dev	NULL
6:1608	NULL
,	NULL
1992	NULL
7	NULL
.	NULL

Murre	NULL
C	NULL
,	NULL
McCaw	NULL
PS	NULL
,	NULL
Baltimore	NULL
D	NULL
:	NULL
A	NULL
new	NULL
DNA	NULL
binding	NULL
and	NULL
dimerization	NULL
motif	NULL
in	NULL
immunoglobulin	NULL
enhancer	NULL
binding	NULL
,	NULL
daughterless	NULL
,	NULL
MyoD	NULL
,	NULL
and	NULL
myc	NULL
proteins	NULL
.	NULL

Cell	NULL
56:777	NULL
,	NULL
1989	NULL
8	NULL
.	NULL

Roberts	NULL
VJ	NULL
,	NULL
Steenbergen	NULL
R	NULL
,	NULL
Murre	NULL
C	NULL
:	NULL
Localization	NULL
of	NULL
E2A	NULL
mRNA	NULL
expression	NULL
in	NULL
developing	NULL
and	NULL
adult	NULL
rat	NULL
tissues	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:7583	NULL
,	NULL
1993	NULL
9	NULL
.	NULL

Inaba	NULL
T	NULL
,	NULL
Shapiro	NULL
LH	NULL
,	NULL
Funabiki	NULL
T	NULL
,	NULL
Sinclair	NULL
AB	NULL
,	NULL
Jones	NULL
BG	NULL
,	NULL
Ashmun	NULL
RA	NULL
,	NULL
Look	NULL
AT	NULL
:	NULL
DNA-binding	NULL
specificity	NULL
and	NULL
trans-activating	NULL
potential	NULL
of	NULL
the	NULL
leukemia-associated	NULL
EZA-hepatic	NULL
leukemia	NULL
factor	NULL
fusion	NULL
protein	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:3403	NULL
,	NULL
1994	NULL
10	NULL
.	NULL

Yoshihara	NULL
T	NULL
,	NULL
Inaba	NULL
T	NULL
,	NULL
Shapiro	NULL
LH	NULL
,	NULL
Kato	NULL
JY	NULL
,	NULL
Look	NULL
AT	NULL
:	NULL
E2A-HLF-mediated	NULL
cell	NULL
transformation	NULL
requires	NULL
both	NULL
the	NULL
trans-activation	NULL
domains	NULL
of	NULL
E2A	NULL
and	NULL
the	NULL
leucine	NULL
zipper	NULL
dimerization	NULL
domain	NULL
of	NULL
HLF	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
15:3247	NULL
,	NULL
1995	NULL
11	NULL
.	NULL

Inaba	NULL
T	NULL
,	NULL
Inukai	NULL
T	NULL
,	NULL
Yoshihara	NULL
T	NULL
,	NULL
Seyschab	NULL
H	NULL
,	NULL
Ashmun	NULL
RA	NULL
,	NULL
Canman	NULL
CB	NULL
,	NULL
Laken	NULL
SJ	NULL
,	NULL
Kastan	NULL
MB	NULL
,	NULL
Look	NULL
AT	NULL
:	NULL
Reversal	NULL
of	NULL
apoptosis	NULL
by	NULL
the	NULL
leukaemia-associated	NULL
EZA-HLF	NULL
chimaeric	NULL
transcription	NULL
factor	NULL
.	NULL

Nature	NULL
382:541	NULL
,	NULL
1996	NULL
12	NULL
.	NULL

Look	NULL
AT	NULL
:	NULL
E2A-HLF	NULL
chimeric	NULL
transcription	NULL
factors	NULL
in	NULL
pro-B	NULL
cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
.	NULL

Curr	NULL
Top	NULL
Microbiol	NULL
Immunol	NULL
220:45	NULL
,	NULL
1997	NULL
13	NULL
.	NULL

Honda	NULL
H	NULL
,	NULL
Fujii	NULL
T	NULL
,	NULL
Takatoku	NULL
M	NULL
,	NULL
Mano	NULL
H	NULL
,	NULL
Witte	NULL
ON	NULL
,	NULL
Yazaki	NULL
YHH	NULL
:	NULL
Expression	NULL
of	NULL
p210	NULL
``	NULL
``	NULL
*	NULL
'	NULL
by	NULL
metallothionein	NULL
promoter	NULL
induced	NULL
T-cell	NULL
leukemia	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Blood	NULL
85:2853	NULL
,	NULL
1995	NULL
14	NULL
.	NULL

Akasaka	NULL
T	NULL
,	NULL
Tsuji	NULL
K	NULL
,	NULL
Kawahira	NULL
H	NULL
,	NULL
Kanno	NULL
M	NULL
,	NULL
Harigaya	NULL
K	NULL
,	NULL
Hu	NULL
L	NULL
,	NULL
Ebinata	NULL
Y	NULL
,	NULL
Nakahata	NULL
T	NULL
,	NULL
Tetsu	NULL
O	NULL
,	NULL
Taniguchi	NULL
M	NULL
,	NULL
Koseki	NULL
H	NULL
:	NULL
The	NULL
role	NULL
of	NULL
mel-18	NULL
,	NULL
a	NULL
mammalian	NULL
Polycomb	NULL
group	NULL
gene	NULL
,	NULL
during	NULL
IL-7-dependent	NULL
proliferation	NULL
of	NULL
lymphocyte	NULL
precursors	NULL
.	NULL

Immunity	NULL
7:135	NULL
,	NULL
1997	NULL
15	NULL
.	NULL

Chomezinski	NULL
P	NULL
,	NULL
Sacchi	NULL
N	NULL
:	NULL
Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
Biochem	NULL
162:156	NULL
,	NULL
1987	NULL
16	NULL
.	NULL

Sgone	NULL
R	NULL
,	NULL
Boeck	NULL
G	NULL
,	NULL
Dietrich	NULL
H	NULL
,	NULL
Gruber	NULL
J	NULL
,	NULL
Recheis	NULL
H	NULL
,	NULL
Wick	NULL
G	NULL
:	NULL
Simultaneous	NULL
determination	NULL
of	NULL
cell	NULL
surface	NULL
antigens	NULL
and	NULL
apoptosis	NULL
.	NULL

Trends	NULL
Genet	NULL
10:41	NULL
,	NULL
1994	NULL
17	NULL
.	NULL

Hardy	NULL
RR	NULL
,	NULL
Carmack	NULL
CB	NULL
,	NULL
Shinton	NULL
SA	NULL
,	NULL
Kemp	NULL
JD	NULL
,	NULL
Hayakawa	NULL
K	NULL
:	NULL
Resolution	NULL
and	NULL
characterization	NULL
of	NULL
pro-B	NULL
and	NULL
pre-pro-B	NULL
cell	NULL
stages	NULL
in	NULL
normal	NULL
mouse	NULL
bone	NULL
marrow	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
173:1213	NULL
,	NULL
1991	NULL
18	NULL
.	NULL

Adams	NULL
JM	NULL
,	NULL
Cory	NULL
S	NULL
:	NULL
Transgenic	NULL
models	NULL
of	NULL
tumor	NULL
development	NULL
.	NULL

Science	NULL
254:1161	NULL
,	NULL
1991	NULL
19	NULL
.	NULL

Heisterkamp	NULL
N	NULL
,	NULL
Jenster	NULL
G	NULL
,	NULL
ten	NULL
Hoeve	NULL
J	NULL
,	NULL
Zovich	NULL
D	NULL
,	NULL
Pattengale	NULL
PK	NULL
,	NULL
Groffen	NULL
J	NULL
:	NULL
Acute	NULL
leukaemia	NULL
in	NULL
ber/abl	NULL
transgenic	NULL
mice	NULL
.	NULL

Nature	NULL
344:251	NULL
,	NULL
1990	NULL
20	NULL
.	NULL

Honda	NULL
H	NULL
,	NULL
Oda	NULL
H	NULL
,	NULL
Suzuki	NULL
T	NULL
,	NULL
Takahashi	NULL
T	NULL
,	NULL
Witte	NULL
ON	NULL
,	NULL
Ozawa	NULL
K	NULL
,	NULL
Ishikawa	NULL
T	NULL
,	NULL
Yazaki	NULL
Y	NULL
,	NULL
Hirai	NULL
H	NULL
:	NULL
Development	NULL
of	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
and	NULL
myeloproliferative	NULL
disorder	NULL
in	NULL
transgenic	NULL
mice	NULL
expressing	NULL
A	NULL
novel	NULL
transgenic	NULL
model	NULL
for	NULL
human	NULL
Ph'-positive	NULL
leukemias	NULL
.	NULL

Blood	NULL
91:2067	NULL
,	NULL
1998	NULL
21	NULL
.	NULL

Brown	NULL
D	NULL
,	NULL
Kogan	NULL
S	NULL
,	NULL
Lagasse	NULL
E	NULL
,	NULL
Weissman	NULL
I	NULL
,	NULL
Alcalay	NULL
M	NULL
,	NULL
Pelicci	NULL
PG	NULL
,	NULL
Atwater	NULL
S	NULL
,	NULL
Bishop	NULL
JM	NULL
:	NULL
A	NULL
PML/RARa	NULL
transgene	NULL
initiates	NULL
murine	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
94:2551	NULL
,	NULL
1997	NULL
2789	NULL
22	NULL
.	NULL

He	NULL
LZ	NULL
,	NULL
Tribioli	NULL
C	NULL
,	NULL
Rivi	NULL
R	NULL
,	NULL
Peruzzi	NULL
D	NULL
,	NULL
Pelicci	NULL
PG	NULL
,	NULL
Soares	NULL
V	NULL
,	NULL
Cattoretti	NULL
G	NULL
,	NULL
Pandolfi	NULL
PP	NULL
:	NULL
Acute	NULL
leukemia	NULL
with	NULL
promyelocytic	NULL
features	NULL
in	NULL
PML/RARa	NULL
transgenic	NULL
mice	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
94:5302	NULL
,	NULL
1997	NULL
23	NULL
.	NULL

Adams	NULL
JM	NULL
,	NULL
Harris	NULL
AW	NULL
,	NULL
Pinkert	NULL
CA	NULL
,	NULL
Corcoran	NULL
LM	NULL
,	NULL
Alexander	NULL
WS	NULL
,	NULL
Cory	NULL
S	NULL
,	NULL
Palmiter	NULL
RD	NULL
,	NULL
Brinster	NULL
RL	NULL
:	NULL
The	NULL
c-myc	NULL
oncogene	NULL
driven	NULL
by	NULL
immunoglobulin	NULL
enhancers	NULL
induces	NULL
lymphoid	NULL
malignancy	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Nature	NULL
318:533	NULL
,	NULL
1985	NULL
24	NULL
.	NULL

Yukawa	NULL
K	NULL
,	NULL
Kikutani	NULL
H	NULL
,	NULL
Inomoto	NULL
T	NULL
,	NULL
Uchira	NULL
M	NULL
,	NULL
Bin	NULL
SH	NULL
,	NULL
Akagi	NULL
K	NULL
,	NULL
Yamamura	NULL
K	NULL
,	NULL
Kishimoto	NULL
T	NULL
:	NULL
Strain	NULL
dependency	NULL
of	NULL
B	NULL
and	NULL
T	NULL
lymphoma	NULL
development	NULL
in	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
enhancer	NULL
(	NULL
Eu	NULL
)	NULL
-myc	NULL
transgenic	NULL
mice	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
170:711	NULL
,	NULL
1989	NULL
25	NULL
.	NULL

Moroy	NULL
T	NULL
,	NULL
Fisher	NULL
P	NULL
,	NULL
Guidos	NULL
C	NULL
,	NULL
Ma	NULL
A	NULL
,	NULL
Zimmerman	NULL
K	NULL
,	NULL
Tesfaye	NULL
A	NULL
,	NULL
DePinho	NULL
R	NULL
,	NULL
Weissman	NULL
I	NULL
,	NULL
Alt	NULL
FW	NULL
:	NULL
IgH	NULL
enhancer	NULL
deregulated	NULL
expression	NULL
of	NULL
L-mye	NULL
:	NULL
Abnormal	NULL
T	NULL
lymphocyte	NULL
development	NULL
and	NULL
T	NULL
cell	NULL
lymphoma-genesis	NULL
.	NULL

EMBO	NULL
J	NULL
9:3659	NULL
,	NULL
1990	NULL
26	NULL
.	NULL

Shull	NULL
MM	NULL
,	NULL
Ormsby	NULL
I	NULL
,	NULL
Kier	NULL
AB	NULL
,	NULL
Pawlowski	NULL
S	NULL
,	NULL
Diebold	NULL
RJ	NULL
,	NULL
Yin	NULL
M	NULL
,	NULL
Allen	NULL
R	NULL
,	NULL
Sidman	NULL
C	NULL
,	NULL
Procetzel	NULL
G	NULL
,	NULL
Calvin	NULL
D	NULL
,	NULL
Annunziata	NULL
N	NULL
,	NULL
Doetschman	NULL
T	NULL
:	NULL
Targeted	NULL
disruption	NULL
of	NULL
the	NULL
mouse	NULL
transforming	NULL
growth	NULL
factor-beta	NULL
1	NULL
gene	NULL
results	NULL
in	NULL
multifocal	NULL
inflammatory	NULL
disease	NULL
.	NULL

Nature	NULL
359:693	NULL
,	NULL
1992	NULL
27	NULL
.	NULL

Tsujimoto	NULL
Y	NULL
,	NULL
Finger	NULL
LR	NULL
,	NULL
Yunis	NULL
J	NULL
,	NULL
C.	NULL
NP	NULL
,	NULL
Croce	NULL
CM	NULL
:	NULL
Cloning	NULL
of	NULL
the	NULL
chromosome	NULL
breakpoint	NULL
of	NULL
neoplastic	NULL
B	NULL
cells	NULL
with	NULL
the	NULL
t	NULL
(	NULL
14	NULL
;	NULL
18	NULL
)	NULL
chromosome	NULL
translocation	NULL
.	NULL

Science	NULL
226:1097	NULL
,	NULL
1984	NULL
28	NULL
.	NULL

Boise	NULL
LH	NULL
,	NULL
Gonzalez-Garcia	NULL
M	NULL
,	NULL
Postema	NULL
CB	NULL
,	NULL
Ding	NULL
L	NULL
,	NULL
Lindsten	NULL
T	NULL
,	NULL
Turka	NULL
LA	NULL
,	NULL
Mao	NULL
X	NULL
,	NULL
Nunez	NULL
G	NULL
,	NULL
Thompson	NULL
CB	NULL
:	NULL
bel-x	NULL
,	NULL
a	NULL
bel-2-related	NULL
gene	NULL
that	NULL
functions	NULL
as	NULL
a	NULL
dominant	NULL
regulator	NULL
of	NULL
apoptotic	NULL
cell	NULL
death	NULL
.	NULL

Cell	NULL
741597	NULL
,	NULL
1993	NULL
29	NULL
.	NULL

Itoh	NULL
N	NULL
,	NULL
Yonehara	NULL
S	NULL
,	NULL
Ishii	NULL
A	NULL
,	NULL
Yonehara	NULL
M	NULL
,	NULL
Mizushima	NULL
S	NULL
,	NULL
Sameshima	NULL
M	NULL
,	NULL
Hase	NULL
A	NULL
,	NULL
Seto	NULL
Y	NULL
,	NULL
Nagata	NULL
S	NULL
:	NULL
The	NULL
polypeptide	NULL
encoded	NULL
by	NULL
the	NULL
cDNA	NULL
for	NULL
human	NULL
cell	NULL
surface	NULL
antigen	NULL
Fas	NULL
can	NULL
mediate	NULL
apoptosis	NULL
.	NULL

Cell	NULL
66:233	NULL
,	NULL
1991	NULL
30	NULL
.	NULL

Inukai	NULL
T	NULL
,	NULL
Inaba	NULL
T	NULL
,	NULL
Ikushima	NULL
S	NULL
,	NULL
Look	NULL
AT	NULL
:	NULL
The	NULL
AD1	NULL
and	NULL
AD2Z	NULL
transactivation	NULL
domains	NULL
of	NULL
EZA	NULL
are	NULL
essential	NULL
for	NULL
the	NULL
antiapoptotic	NULL
activity	NULL
of	NULL
the	NULL
E2A-HLF	NULL
chimeric	NULL
oncoprotein	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
18:6035	NULL
,	NULL
1998	NULL
31	NULL
.	NULL

Goi	NULL
K	NULL
,	NULL
Kurosawa	NULL
H	NULL
,	NULL
Inaba	NULL
T	NULL
,	NULL
Meltzer	NULL
PS	NULL
,	NULL
Look	NULL
AT	NULL
:	NULL
Downstream	NULL
target	NULL
genes	NULL
for	NULL
E2A-HLF	NULL
indentified	NULL
by	NULL
cDNA	NULL
microarray	NULL
analysis	NULL
.	NULL

Blood	NULL
92:590a	NULL
,	NULL
1998	NULL
(	NULL
abstr	NULL
,	NULL
suppl	NULL
1	NULL
)	NULL
32	NULL
.	NULL

Dedera	NULL
DA	NULL
,	NULL
Waller	NULL
EK	NULL
,	NULL
LeBrun	NULL
DP	NULL
,	NULL
Sen-Majumdar	NULL
A	NULL
,	NULL
Stevens	NULL
ME	NULL
,	NULL
Barsh	NULL
GS	NULL
,	NULL
Cleary	NULL
ML	NULL
:	NULL
Chimeric	NULL
homeobox	NULL
gene	NULL
EZA-PBX1	NULL
induces	NULL
proliferation	NULL
,	NULL
apoptosis	NULL
,	NULL
and	NULL
malignant	NULL
lymphomas	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Cell	NULL
74:833	NULL
,	NULL
1993	NULL
33	NULL
.	NULL

Lu	NULL
Q	NULL
,	NULL
Wright	NULL
DD	NULL
,	NULL
Kamps	NULL
MP	NULL
:	NULL
Fusion	NULL
with	NULL
EZA	NULL
converts	NULL
the	NULL
Pbx1	NULL
homeodomain	NULL
protein	NULL
into	NULL
a	NULL
constitutive	NULL
transcriptional	NULL
activator	NULL
in	NULL
human	NULL
leukemias	NULL
carrying	NULL
the	NULL
t	NULL
(	NULL
1	NULL
;	NULL
19	NULL
)	NULL
translocation	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:3938	NULL
,	NULL
1994	NULL
34	NULL
.	NULL

Bain	NULL
G	NULL
,	NULL
Maandag	NULL
EC	NULL
,	NULL
Izon	NULL
DJ	NULL
,	NULL
Amsen	NULL
D	NULL
,	NULL
Kruisbeck	NULL
AM	NULL
,	NULL
Weintraub	NULL
BC	NULL
,	NULL
Krop	NULL
I	NULL
,	NULL
Schlissel	NULL
MS	NULL
,	NULL
Feeney	NULL
AJ	NULL
,	NULL
van	NULL
Roon	NULL
M	NULL
,	NULL
van	NULL
der	NULL
Valk	NULL
M	NULL
,	NULL
te	NULL
Ricle	NULL
HPJ	NULL
,	NULL
Berns	NULL
A	NULL
,	NULL
Murre	NULL
C	NULL
:	NULL
E2A	NULL
proteins	NULL
are	NULL
required	NULL
for	NULL
proper	NULL
B	NULL
cell	NULL
development	NULL
and	NULL
initiation	NULL
of	NULL
immunoglobulin	NULL
gene	NULL
rearrangements	NULL
.	NULL

Cell	NULL
79:885	NULL
,	NULL
1994	NULL
35	NULL
.	NULL

Zhuang	NULL
Y	NULL
,	NULL
Soriano	NULL
P	NULL
,	NULL
Weintraub	NULL
H	NULL
:	NULL
The	NULL
helix-loop-helix	NULL
gene	NULL
E2A	NULL
is	NULL
required	NULL
for	NULL
B	NULL
cell	NULL
formation	NULL
.	NULL

Cell	NULL
79:875	NULL
,	NULL
1994	NULL
36	NULL
.	NULL

Bain	NULL
G	NULL
,	NULL
Engel	NULL
I	NULL
,	NULL
Robanus	NULL
Maandag	NULL
EC	NULL
,	NULL
te	NULL
Riele	NULL
HP	NULL
,	NULL
Voland	NULL
JR	NULL
,	NULL
Sharp	NULL
LL	NULL
,	NULL
Chun	NULL
J	NULL
,	NULL
Huey	NULL
B	NULL
,	NULL
Pinkel	NULL
D	NULL
,	NULL
Murre	NULL
C	NULL
:	NULL
E2A	NULL
deficiency	NULL
leads	NULL
to	NULL
abnormalities	NULL
in	NULL
Â«	NULL
B	NULL
T-cell	NULL
development	NULL
and	NULL
to	NULL
rapid	NULL
development	NULL
of	NULL
T-cell	NULL
lymphomas	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
17:4782	NULL
,	NULL
1997	NULL
37	NULL
.	NULL

Inukai	NULL
T	NULL
,	NULL
Inaba	NULL
T	NULL
,	NULL
Yoshibara	NULL
T	NULL
,	NULL
Look	NULL
AT	NULL
:	NULL
Cell	NULL
transformation	NULL
mediated	NULL
by	NULL
homodimeric	NULL
Â£2A-HLF	NULL
transcription	NULL
factor	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
17:1413	NULL
,	NULL
1997	NULL
38	NULL
.	NULL

Monica	NULL
K	NULL
,	NULL
LeBrun	NULL
DP	NULL
,	NULL
Dedera	NULL
DA	NULL
,	NULL
Brown	NULL
R	NULL
,	NULL
Cleary	NULL
ML	NULL
:	NULL
Transformation	NULL
properties	NULL
of	NULL
the	NULL
EZa-Pbx1	NULL
chimeric	NULL
oncoprotein	NULL
:	NULL
Fusion	NULL
with	NULL
E2a	NULL
is	NULL
essential	NULL
,	NULL
but	NULL
the	NULL
Pbx1	NULL
homeodomain	NULL
is	NULL
dispensable	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:8304	NULL
,	NULL
1994	NULL
39	NULL
.	NULL

Kamps	NULL
MP	NULL
,	NULL
Wright	NULL
DD	NULL
,	NULL
Lu	NULL
Q	NULL
:	NULL
DNA-binding	NULL
by	NULL
oncoprotein	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2790	NULL
E2A-Pbx1	NULL
is	NULL
important	NULL
for	NULL
blocking	NULL
differentiation	NULL
but	NULL
dispensable	NULL
for	NULL
fibroblast	NULL
transformation	NULL
.	NULL

Oncogene	NULL
12:19	NULL
,	NULL
1996	NULL
40	NULL
.	NULL

Hsu	NULL
HL	NULL
,	NULL
Cheng	NULL
JT	NULL
,	NULL
Chen	NULL
Q	NULL
,	NULL
Baer	NULL
R	NULL
:	NULL
Enhancer-binding	NULL
activity	NULL
of	NULL
the	NULL
tal-1	NULL
oncoprotein	NULL
in	NULL
association	NULL
with	NULL
the	NULL
E47/E12	NULL
helix-loop-helix	NULL
proteins	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
11:3037	NULL
,	NULL
1991	NULL
41	NULL
.	NULL

Hsu	NULL
HL	NULL
,	NULL
Wadman	NULL
I	NULL
,	NULL
Baer	NULL
R	NULL
:	NULL
Formation	NULL
of	NULL
in	NULL
vivo	NULL
complexes	NULL
HONDA	NULL
ET	NULL
AL	NULL
between	NULL
the	NULL
Tall	NULL
and	NULL
EZA	NULL
polypeptides	NULL
of	NULL
leukemic	NULL
T	NULL
cells	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
91:3181	NULL
,	NULL
1994	NULL
42	NULL
.	NULL

Larson	NULL
RC	NULL
,	NULL
Lavenir	NULL
I	NULL
,	NULL
Larson	NULL
TA	NULL
,	NULL
Baer	NULL
R	NULL
,	NULL
Warren	NULL
AJ	NULL
,	NULL
Wadman	NULL
I	NULL
,	NULL
Nottage	NULL
K	NULL
,	NULL
Rabbitts	NULL
TH	NULL
:	NULL
Protein	NULL
dimerization	NULL
between	NULL
Lmo2	NULL
(	NULL
Rbtn2	NULL
)	NULL
and	NULL
Tall	NULL
alters	NULL
thymocyte	NULL
development	NULL
and	NULL
potentiates	NULL
T	NULL
cell	NULL
tumorigen-esis	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

EMBO	NULL
J	NULL
15:1021	NULL
,	NULL
1996	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Â®	NULL
blO	NULL
0d	NULL
1999	NULL
93	NULL
:	NULL
2780-2790	NULL
Expression	NULL
of	NULL
E2A-HLF	NULL
Chimeric	NULL
Protein	NULL
Induced	NULL
T-Cell	NULL
Apoptosis	NULL
,	NULL
B-Cell	NULL
Maturation	NULL
Arrest	NULL
,	NULL
and	NULL
Development	NULL
of	NULL
Acute	NULL
Lymphoblastic	NULL
Leukemia	NULL
Hiroaki	NULL
Honda	NULL
,	NULL
Toshiya	NULL
Inaba	NULL
,	NULL
Takahiro	NULL
Suzuki	NULL
,	NULL
Hideaki	NULL
Oda	NULL
,	NULL
Yasuhiro	NULL
Ebihara	NULL
,	NULL
Kohichiro	NULL
Tsuji	NULL
,	NULL
Tatsutoshi	NULL
Nakahata	NULL
,	NULL
Takatoshi	NULL
Ishikawa	NULL
,	NULL
Yoshio	NULL
Yazaki	NULL
and	NULL
Hisamaru	NULL
Hirai	NULL
4	NULL
QM	NULL
â	NULL
Caw	NULL
,	NULL
.	NULL

,	NULL
'	NULL
\se	NULL
@	NULL
.	NULL

2	NULL
YOtowÂ®	NULL
@	NULL
207	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/93/9/2780.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

